NCT00003243
Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer treatment 1 completed NCT00415103
AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors No drug interventions treatment 4 completed NCT05842603
I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients No drug interventions supportive_care Not Available recruiting NCT04092803
Virtual Reality as a Distraction Technique for Performing Lumbar Punctures in Children and Young Adu No drug interventions supportive_care Not Available completed NCT00000603
Cord Blood Stem Cell Transplantation Study (COBLT) No drug interventions treatment 2 completed NCT01057303
Studying Gene Expression in Tissue Samples From Young Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00525603
CFAR Study in Patients With Chronic Lymphocytic Leukemia No drug interventions treatment 2 completed NCT00082303
Music Imagery for Patients Receiving Chemotherapy for Leukemia or Non-Hodgkin's Lymphoma No drug interventions treatment 1 / 2 completed NCT00030303
Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia No drug interventions treatment 1 completed NCT03708003
Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL No drug interventions treatment 2 active_not_recruiting NCT01254890
Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome No drug interventions treatment 1 / 2 completed NCT00935090
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer No drug interventions diagnostic Not Available recruiting NCT00179790
Reduced Intensity Transplant Using Extracorporeal Photopheresis No drug interventions treatment 1 / 2 completed NCT00002790
Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant supportive_care 1 / 2 withdrawn NCT00008190
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia treatment 2 completed NCT00003790
Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome No drug interventions Not Available Not Available completed NCT00002890
Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous Leukemia treatment 1 completed NCT00186290
Allo BMT in Advanced Leukemia or High Grade Lymphoma No drug interventions treatment Not Available completed NCT03836690
Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation No drug interventions treatment 1 unknown_status NCT01057290
Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00814164
Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia No drug interventions treatment 2 terminated NCT01431664
AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia No drug interventions treatment 1 completed NCT00948064
Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) No drug interventions treatment 2 completed NCT00964821
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant No drug interventions Not Available Not Available completed NCT04688021
A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT. No drug interventions prevention 2 recruiting NCT00047021
Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma treatment 2 completed NCT02409121
A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers No drug interventions supportive_care Not Available completed NCT03326921
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant No drug interventions treatment 1 suspended NCT01168921
Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL) No drug interventions treatment 2 completed NCT01498302
Comparison of Laboratory Test Results of Minimal-Residual Disease in Samples From Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00068302
Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma treatment 1 terminated NCT03496402
Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) No drug interventions other Not Available recruiting NCT00771602
Alemtuzumab + Rituximab Consolidation in CLL No drug interventions treatment 2 terminated NCT00589602
T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases No drug interventions treatment 2 terminated NCT00005802
Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia treatment 1 / 2 completed NCT01390402
Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG No drug interventions treatment 2 completed NCT00002502
Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome treatment 2 completed NCT01497184
Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood No drug interventions treatment 1 completed NCT02564484
iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy No drug interventions Not Available Not Available completed NCT01436084
SB1518 for Patients With Myelodysplastic Syndrome (MDS) No drug interventions treatment 2 terminated NCT01088984
Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia No drug interventions treatment 1 / 2 completed NCT04840784
First-in Human (FIH) Trial of ETH-155008 in Subjects With B-NHL, CLL/SLL and AML No drug interventions treatment 1 terminated NCT02981784
Comparative Evaluation of Results of Allogeneic Hematopoietic Stem Cells Versus Ponatinib in CML Patients Carrying a Mutation T315I No drug interventions Not Available Not Available completed NCT00004084
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia No drug interventions treatment 1 / 2 completed NCT00293384
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant No drug interventions supportive_care Not Available completed NCT01542684
Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS) No drug interventions treatment 2 terminated NCT00005984
Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia treatment 2 terminated NCT00255684
Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer No drug interventions treatment Not Available terminated NCT00576979
Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia No drug interventions treatment 1 / 2 active_not_recruiting NCT00782379
Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer No drug interventions treatment 2 completed NCT00005579
Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia treatment 2 completed NCT00049179
S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia treatment 2 completed NCT02305979
Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies No drug interventions Not Available Not Available completed NCT00631579
Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma No drug interventions treatment 2 completed NCT00997243
Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes No drug interventions treatment 2 terminated NCT00262743
Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia No drug interventions treatment 1 / 2 completed NCT00899743
S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT01137643
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer No drug interventions Not Available Not Available recruiting NCT05866887
Insomnia Prevention in Children With Acute Lymphoblastic Leukemia No drug interventions supportive_care Not Available completed NCT00015587
Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) No drug interventions Not Available Not Available completed NCT04100187
Immunotherapy With CD19 CAR T-cells for B-Cell Leukemia No drug interventions treatment 1 not_yet_recruiting NCT03538587
Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers No drug interventions supportive_care Not Available completed NCT00093587
Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia supportive_care Not Available unknown_status NCT00003687
Treatment for Chronic Pain in Patients With Advanced Cancer supportive_care 3 completed NCT00053287
Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS treatment 2 completed NCT00081887
Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia treatment 1 terminated NCT00365287
Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer No drug interventions treatment 1 / 2 completed NCT00003887
Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation No drug interventions treatment 2 completed NCT00582933
Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor No drug interventions treatment 2 completed NCT01139333
Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT02192333
Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors No drug interventions supportive_care Not Available completed NCT00001333
Phase I Study of Intrathecal Topotecan treatment 1 completed NCT00620633
Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation No drug interventions treatment 1 completed NCT00004933
Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa treatment 3 terminated NCT00044954
Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00005854
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00002554
Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse treatment 2 completed NCT00018954
Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma treatment 2 completed NCT00405054
A Phase II Study of MK0457 in Patients With T315I Mutant CML and Ph+All (0457-008) No drug interventions treatment 2 terminated NCT00107354
Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant treatment 1 completed NCT00082654
Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients No drug interventions Not Available Not Available completed NCT00015951
Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers treatment 2 completed NCT00006451
Bone Marrow Transplantation in Treating Patients With Leukemia treatment 3 withdrawn NCT00899951
Studying Fentanyl in Patients With Cancer Not Available Not Available terminated NCT01162551
Trial of Sirolimus and Methotrexate in Relapsed/Refractory Lymphoblastic Leukemia and Lymphoma treatment 2 completed NCT00473551
Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies No drug interventions treatment 1 terminated NCT00008151
Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome treatment 2 completed NCT02095951
Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection treatment 4 completed NCT00026351
Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia treatment 2 completed NCT00416351
Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment No drug interventions treatment 1 / 2 completed NCT00301951
Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer No drug interventions treatment 1 completed NCT01139151
4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies treatment 1 completed NCT00006053
STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa treatment 2 completed NCT00011453
Protection Against Benzene Toxicity No drug interventions Not Available Not Available completed NCT05375253
Donor Enriched Activated NK Cell Infusion Post Haploidentical Stem Cell Transplant for Refractory Myeloid Malignancies treatment 1 withdrawn NCT05190653
Early Integration of Palliative and Supportive Care in Cellular Therapy No drug interventions supportive_care Not Available recruiting NCT02935153
A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies No drug interventions treatment 1 / 2 unknown_status NCT01518153
Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT) treatment 2 terminated NCT02668653
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML) treatment 3 completed NCT00313053
Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia No drug interventions treatment 1 terminated NCT00101153
Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia treatment 1 completed NCT00840177
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia treatment 2 completed NCT01218477
Dasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML) treatment 1 / 2 completed NCT00546377
Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer No drug interventions treatment 1 / 2 completed NCT00425477
Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia No drug interventions treatment 2 completed NCT03052777
Using Telephone Counselling to Improve Exercise Participation in Hematologic Cancer Survivors No drug interventions supportive_care Not Available completed NCT00261677
A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy No drug interventions treatment 3 completed NCT04853277
Patient Reported Outcomes and Patient Education in Cellular Therapy Patients No drug interventions prevention Not Available completed NCT02141477
Omacetaxine and Decitabine in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) treatment 1 terminated NCT00126477
Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer No drug interventions Not Available Not Available completed NCT02272777
A Study of Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase treatment 3 completed NCT00023777
S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia treatment 2 completed NCT02537977
CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy No drug interventions treatment 1 / 2 unknown_status NCT00428077
Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia No drug interventions treatment 2 terminated NCT00005977
Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia treatment 3 completed NCT01202877
PKC412 and 5-Azacytidine treatment 1 / 2 completed NCT00100477
Use of Topotecan in Patients With Refractory Acute Leukemia Not Available 2 completed NCT00586547
Evaluating the Use of RFT5-dgA to Deplete Alloreactive Cells Prior to Haploidentical Stem Cell Transplantation No drug interventions treatment 1 completed NCT06578247
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML treatment 3 not_yet_recruiting NCT00015847
Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia treatment 2 terminated NCT00186147
Bone Marrow Grafting for Leukemia and Lymphoma No drug interventions Not Available Not Available enrolling_by_invitation NCT00398047
Azacitidine, Darbepoetin Alfa, and Erythropoietin and Filgastrim (G-CSF) in Treating Patients With Myelodysplastic Syndromes No drug interventions treatment 2 terminated NCT00004047
Chemotherapy in Treating Patients Who Have Hematologic Cancer treatment 1 completed NCT00027547
Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia treatment 1 / 2 completed NCT00829647
A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia treatment 1 / 2 withdrawn NCT01137747
Carfilzomib in Patients With Relapsed Acute Myeloid or Acute Lymphoblastic Leukemia treatment 1 completed NCT00513747
Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia No drug interventions treatment 3 terminated NCT05011045
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies No drug interventions Not Available Not Available recruiting NCT01498445
An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357) treatment 1 / 2 terminated NCT00025545
Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia</p> treatment 2 completed NCT01272245
Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) treatment 2 completed NCT00003545
506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma treatment 2 completed NCT02053545
Haplo-identical SCT for High Risk (HR) Hematologic Malignancies w/Post-Transplant In-Vivo T-cell Depletion No drug interventions treatment 1 / 2 withdrawn NCT00042445
Brain Neoplasms, Leukemia and Petrochemical Exposures No drug interventions Not Available Not Available completed NCT03126045
A Randomized Study Evaluating the Incidence of Post Lumbar Puncture Headache With Atraumatic Needles in Hematology No drug interventions prevention Not Available completed NCT02010645
Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS) treatment 2 terminated NCT00005945
Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia treatment 3 completed NCT02897245
A Study for Tyrosine Kinase Inhibitors Discontinuation No drug interventions Not Available Not Available unknown_status NCT03145545
Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC No drug interventions Not Available Not Available available NCT00002945
High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia treatment 3 completed NCT00004898
Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia treatment 1 / 2 completed NCT03262298
Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies No drug interventions treatment 1 / 2 unknown_status NCT01460498
Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML) treatment 1 completed NCT00003398
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer treatment 4 completed NCT00528398
Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia No drug interventions treatment 2 completed NCT00009698
Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia treatment 1 completed NCT00003305
Aminopterin in Treating Patients With Refractory Leukemia treatment 2 completed NCT00003805
Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count supportive_care 3 completed NCT00502905
Busulfan and Fludarabine in Patients With AML and MDS No drug interventions treatment 2 completed NCT03312205
CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies No drug interventions treatment 1 / 2 unknown_status NCT00045305
Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes treatment 2 completed NCT00713505
Educational and Skills Training Program for Parents of Childhood Cancer Survivors Who Have Neurobehavioral Dysfunction No drug interventions Not Available Not Available completed NCT00005805
St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer No drug interventions supportive_care 3 completed NCT00003005
Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia treatment 1 completed NCT00006097
Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia treatment 1 / 2 completed NCT00003997
6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia treatment 1 completed NCT00005797
Bone Marrow Transplant in Treating Patients With Hematologic Cancers treatment 2 completed NCT00506597
Erwinase Study in Patients With Acute Lymphoblastic Leukemia No drug interventions treatment Not Available completed NCT01692197
E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes treatment 2 completed NCT00502983
Molecular Epidemiology of Acute Myelogenous Leukemia No drug interventions Not Available Not Available unknown_status NCT00816283
Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia treatment 1 completed NCT00450983
Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases No drug interventions treatment 2 terminated NCT01230983
Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma supportive_care 3 completed NCT00946283
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome No drug interventions supportive_care Not Available terminated NCT02709083
Dasatinib or Nilotinib Followed by Imatinib in Patients With Newly Diagnosed, Chronic Phase Chronic Myeloid Leukemia treatment 2 terminated NCT00093483
Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia treatment 1 completed NCT01626183
Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT00112983
Eculizumab in Treating Patients With Paroxysmal Nocturnal Hemoglobinuria No drug interventions prevention 3 completed NCT00707083
Two Combination Chemotherapy Regimens in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia No drug interventions treatment 3 completed NCT00003561
Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia treatment 2 terminated NCT02484261
Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children treatment 1 terminated NCT00003661
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00578461
T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE No drug interventions treatment Not Available terminated NCT00003361
Decitabine in Treating Patients With Myelodysplastic Syndrome treatment 2 completed NCT00003861
Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia No drug interventions Not Available Not Available active_not_recruiting NCT00898261
Gene Expression in Tissue From Patients With Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT00818961
Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer treatment 2 terminated NCT00233961
G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission No drug interventions treatment 1 completed NCT00004061
Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer supportive_care 2 completed NCT02141828
A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene treatment 1 completed NCT00731328
Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome No drug interventions treatment 2 completed NCT00356928
Cyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic Malignancies No drug interventions treatment 1 terminated NCT01395628
Cell Samples From Patients With Leukemia No drug interventions Not Available Not Available completed NCT01807611
Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy treatment 2 completed NCT04496011
Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation No drug interventions treatment Not Available unknown_status NCT00064311
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation supportive_care 1 / 2 completed NCT00809211
Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia treatment 2 completed NCT00775593
Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia treatment 2 completed NCT00109993
Campath-1H + FK506 and Methylprednisolone for GVHD supportive_care 2 completed NCT00003593
Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome treatment 3 completed NCT00602693
T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer No drug interventions treatment 1 completed NCT00453193
Alemtuzumab and Pentostatin In T-cell Neoplasms No drug interventions treatment 2 terminated NCT00003793
Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma No drug interventions Not Available Not Available completed NCT00372593
Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia No drug interventions treatment 3 completed NCT00077493
BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma No drug interventions treatment 1 suspended NCT00002693
Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia treatment 1 completed NCT00295971
Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease No drug interventions treatment 1 completed NCT00054171
Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia treatment 2 completed NCT00808171
Evaluation of the Analgesy With Emla and/or Nitrous Oxide in Pediatric Patients for Lumbar Puncture supportive_care 4 completed NCT00258271
Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia No drug interventions treatment 1 completed NCT00666978
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking No drug interventions treatment 4 completed NCT01326078
Use of Lipid Emulsion or Nanoemulsion of Propofol on Children Undergoing Ambulatory Invasive Procedures. supportive_care 2 / 3 withdrawn NCT00577278
A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan No drug interventions treatment 2 completed NCT00003178
Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia treatment 2 completed NCT05865678
Musculoskeletal Health in Adult Haematological Cancer Survivors No drug interventions Not Available Not Available recruiting NCT02477878
Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant treatment 1 active_not_recruiting NCT00536978
Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies No drug interventions treatment 2 completed NCT01288378
Empirical Versus Preemptive Antifungal Therapy supportive_care 3 completed NCT00982488
Long-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia treatment 2 completed NCT00342888
Case-Control Study of Pesticides and Childhood Leukemia No drug interventions Not Available Not Available completed NCT00005988
Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy treatment 1 completed NCT00002588
Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia treatment 1 completed NCT03722407
Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion treatment 2 active_not_recruiting NCT00003107
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors treatment 1 completed NCT06469307
Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE) No drug interventions Not Available Not Available not_yet_recruiting NCT00212407
New York Blood Center National Cord Blood Program No drug interventions treatment 0 terminated NCT04077307
A Study in Leukemia Patients With Karonudib No drug interventions treatment 1 recruiting NCT01035307
Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421 No drug interventions Not Available Not Available completed NCT01139307
Biomarkers in Samples From Patients With Down Syndrome and Acute Megakaryoblastic Leukemia No drug interventions Not Available Not Available completed NCT02270307
MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis prevention 2 / 3 unknown_status NCT00008307
Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders treatment 2 unknown_status NCT00019409
Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia treatment 3 withdrawn NCT00004009
R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia treatment 1 completed NCT01164709
Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer treatment 1 completed NCT00750009
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial No drug interventions other 3 completed NCT06152809
CIML NK Cells With Venetoclax for AML treatment 1 active_not_recruiting NCT00492856
S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia No drug interventions treatment 3 completed NCT00898456
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available active_not_recruiting NCT00002456
Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation supportive_care 3 completed NCT02399956
Lactation Outcomes Among Survivors of Pediatric Cancer No drug interventions Not Available Not Available completed NCT00003056
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation supportive_care 3 terminated NCT00503256
Genetic Study of Chronic Lymphocytic Leukemia Families No drug interventions Not Available Not Available unknown_status NCT01229956
Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00002756
Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia treatment 2 completed NCT00002785
Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia treatment 2 completed NCT00698685
Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation No drug interventions treatment 2 terminated NCT00952185
Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers No drug interventions supportive_care Not Available terminated NCT04406285
Effects of Periodized and Autoregulated Resistance Training in Haematological Cancer Patients During the Treatent. No drug interventions treatment Not Available unknown_status NCT01200485
Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2 treatment 2 completed NCT01321385
Biomarkers in Predicting Response to Treatment in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00499785
Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT02328885
Prophylactic Infusion of Donor Lymphocytes in Cord Blood Transplantation No drug interventions treatment 1 / 2 completed NCT00002485
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer No drug interventions Not Available Not Available completed NCT00003885
Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma treatment 2 unknown_status NCT02583815
Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP) No drug interventions Not Available Not Available completed NCT01174615
Collection of Blood and/or Bone Marrow for Investigation and Characterization of Normal and Abnormal Cell Growth No drug interventions Not Available Not Available recruiting NCT00544115
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders No drug interventions treatment 2 active_not_recruiting NCT00691015
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant No drug interventions supportive_care 2 completed NCT04856215
90Y-labelled Anti-CD66 ab in Childhood High Risk Leukaemia No drug interventions treatment 2 recruiting NCT02423915
Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention treatment 1 completed NCT00427115
Multimodal Intervention in Allogeneic Stem Cell Transplantation No drug interventions supportive_care 3 completed NCT00024115
BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia No drug interventions treatment 1 withdrawn NCT05784415
Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell No drug interventions Not Available Not Available active_not_recruiting NCT00510315
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant No drug interventions Not Available Not Available completed NCT00003415
Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome treatment 1 / 2 completed NCT05131815
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors No drug interventions supportive_care Not Available active_not_recruiting NCT00004215
Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia supportive_care 2 completed NCT04026737
Cardiovascular Effects of CART Cell Therapy No drug interventions Not Available Not Available completed NCT00109837
S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia treatment 2 completed NCT00089037
Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation supportive_care 1 / 2 completed NCT06336837
False Positive Peripheral Blood Culture in Children With Leukaemia: A Prevalence Study No drug interventions Not Available Not Available completed NCT00606437
Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants No drug interventions treatment 1 completed NCT02234037
Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60 treatment 1 terminated NCT00245037
Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer No drug interventions treatment 1 / 2 completed NCT00003837
506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma treatment Not Available completed NCT00048737
Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies treatment 1 / 2 completed NCT06313437
Revumenib in Combination With 7+3 + Midostaurin in AML treatment 1 not_yet_recruiting NCT00795132
Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies treatment 2 completed NCT00489632
Children's Resiliency, Adjustment, and Coping No drug interventions Not Available Not Available completed NCT00004232
Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer supportive_care 1 completed NCT00052832
Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia No drug interventions treatment 2 completed NCT00019032
Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia No drug interventions treatment 1 completed NCT00462332
Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia No drug interventions treatment 2 completed NCT01315132
A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies No drug interventions treatment 2 completed NCT02773732
Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101) treatment 1 / 2 terminated NCT00004932
STI571 in Treating Patients With Recurrent Leukemia treatment 1 completed NCT00002832
Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia treatment 1 / 2 completed NCT00006052
STI571 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia treatment 2 completed NCT00006252
Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma treatment 2 completed NCT00005852
Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant treatment 2 terminated NCT02223052
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies treatment 1 completed NCT00004052
Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia No drug interventions treatment 2 completed NCT02910752
CLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell Transplantation No drug interventions treatment 1 / 2 suspended NCT00890552
A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis treatment Not Available completed NCT03251352
TKI Discontinuation in CML Patients of China No drug interventions Not Available Not Available unknown_status NCT01608152
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors No drug interventions Not Available Not Available recruiting NCT00003700
Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia treatment 2 completed NCT01541800
Circulating microRNAs as Disease Markers in Pediatric Cancers No drug interventions Not Available Not Available unknown_status NCT00002800
Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome treatment 2 completed NCT00003600
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy supportive_care 3 completed NCT02193100
Pre and Post Treatment Metabolomic Analysis of Leukemia: A Translational Clinical Trial of the Brown Cancer Center No drug interventions Not Available Not Available withdrawn NCT00234000
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes No drug interventions treatment 1 terminated NCT04271800
Safety and Efficacy of CD19-Targeted CAR-T Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma No drug interventions treatment 1 / 2 recruiting NCT06021600
A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine treatment 1 recruiting NCT00357500
Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer No drug interventions treatment 2 completed NCT01027000
Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma treatment 2 completed NCT00499759
Individualized Exercise Programs for Patients Receiving Chemotherapy for Newly Diagnosed Acute or Relapsed Myeloid Leukemia or Lymphoblastic Leukemia No drug interventions supportive_care Not Available completed NCT04466059
Better Leukemia Diagnostics Through AI (BELUGA) No drug interventions Not Available Not Available recruiting NCT01251159
Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00469859
Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia No drug interventions treatment 1 / 2 completed NCT00897559
Study of Bone Marrow Samples From Patients With Acute Leukemia No drug interventions Not Available Not Available completed NCT05282459
Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation supportive_care 1 / 2 recruiting NCT00016159
Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia treatment 2 completed NCT00346359
Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer No drug interventions treatment 2 completed NCT01141959
Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients No drug interventions Not Available Not Available completed NCT00956475
Quality of Life in Younger Leukemia and Lymphoma Survivors No drug interventions Not Available Not Available completed NCT01511575
Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder No drug interventions Not Available Not Available completed NCT00104975
Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer treatment 1 completed NCT00176475
Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease No drug interventions treatment 1 terminated NCT01904175
Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant No drug interventions Not Available Not Available completed NCT00558675
A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy No drug interventions treatment 1 / 2 completed NCT00049075
Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia treatment 2 completed NCT04136275
CAR-37 T Cells In Hematologic Malignancies No drug interventions treatment 1 completed NCT05840575
Investigating Cognitive Impairment in Young Patients With Cancer Prospectively No drug interventions Not Available Not Available recruiting NCT02763475
NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents treatment 2 completed NCT00003870
Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia treatment 2 completed NCT00214370
Propofol Versus Propofol-Fentanyl as Sedation For Lumbar Puncture in Children With Acute Leukemia/Lymphoma No drug interventions treatment Not Available completed NCT00020670
Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia No drug interventions treatment 0 terminated NCT00562770
Oral Valganciclovir Versus Valacyclovir No drug interventions treatment 2 completed NCT02320942
Exercise Post Bone Marrow Transplant No drug interventions supportive_care Not Available unknown_status NCT01232842
Biomarker Study in Tissue Samples From Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT01444742
Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS) treatment 2 completed NCT01895842
Ruxolitinib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) treatment 1 completed NCT00309842
Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases No drug interventions treatment 2 completed NCT00578942
Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath No drug interventions treatment 2 completed NCT00006042
Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer treatment 1 completed NCT00002742
Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer supportive_care 3 completed NCT01500499
Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT05393999
SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations No drug interventions prevention 2 withdrawn NCT01505699
Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT00544999
Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia No drug interventions treatment 1 unknown_status NCT00004899
Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome treatment 2 completed NCT00002499
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia treatment 2 / 3 unknown_status NCT01396499
Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced Leukemias treatment 1 completed NCT04645199
National Longitudinal Cohort of Hematological Diseases No drug interventions Not Available Not Available recruiting NCT00052299
Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia treatment 3 completed NCT00661999
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer No drug interventions supportive_care 3 completed NCT02331706
IFN-DLI for Relapsed Acute Leukemia After Allo-SCT treatment 0 completed NCT00104806
Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes treatment 2 terminated NCT00900406
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant No drug interventions Not Available Not Available completed NCT00645606
Rituximab Maintenance Versus Observation After First-line Immunochemotherapy by FCR in Older Patients With Chronic Lymphocytic Leukemia No drug interventions treatment 3 completed NCT00882206
Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia treatment 2 terminated NCT02274506
Infusion of Allogeneic, 3rd Party CD19-specific T Cells treatment 1 withdrawn NCT01191749
Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL) treatment 2 terminated NCT02356549
African American Cancer Clinical Trial Decisions: Testing Tailored Messages No drug interventions other Not Available completed NCT00818649
Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia treatment 2 terminated NCT00502749
Exercise Program for Adolescents and Young Adults With Cancer No drug interventions supportive_care Not Available completed NCT02599649
Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS) treatment 2 terminated NCT02710149
A Clinical Research of CD20-Targeted CAR-T in B Cell Malignancies No drug interventions treatment 1 / 2 unknown_status NCT00002549
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia treatment 3 unknown_status NCT00001336
In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients No drug interventions Not Available Not Available completed NCT00004036
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer supportive_care 1 unknown_status NCT00777036
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib treatment 2 active_not_recruiting NCT00679536
Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors No drug interventions treatment 1 / 2 unknown_status NCT00003436
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia treatment 3 completed NCT05464836
Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBL treatment 2 terminated NCT00602836
Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma No drug interventions treatment 2 completed NCT00709813
Study to Test a Computer-assisted Support System to Improve Patient-centered Care and Symptom Relief in Cancer Patients No drug interventions supportive_care Not Available completed NCT05692713
Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201) No drug interventions Not Available Not Available recruiting NCT00049413
Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma treatment 2 completed NCT01118013
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant treatment 2 terminated NCT04074213
Clozapine and Haematologic Malignancies: Observational and Retrospective Study Using the WHO Pharmacovigilance Database Not Available Not Available unknown_status NCT00045513
Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma treatment 1 / 2 completed NCT00105313
Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia treatment 1 terminated NCT00003913
Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease treatment 2 completed NCT00816413
Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer treatment 1 / 2 withdrawn NCT05309213
Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia No drug interventions treatment 1 / 2 not_yet_recruiting NCT01653613
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available unknown_status NCT06360718
Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress. No drug interventions supportive_care Not Available recruiting NCT00028418
Clofarabine in Chronic Lymphocytic Leukemia treatment 1 completed NCT00002718
T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia treatment 2 completed NCT00436618
Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment No drug interventions treatment 2 completed NCT01254318
Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501) No drug interventions Not Available Not Available completed NCT00004218
Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia treatment 3 completed NCT00304018
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer No drug interventions treatment 1 completed NCT00430118
Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia No drug interventions treatment 3 completed NCT00530218
Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant No drug interventions supportive_care 2 completed NCT00669318
Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma No drug interventions treatment 2 completed NCT00686218
Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia No drug interventions treatment 1 completed NCT00055718
Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy No drug interventions supportive_care 2 completed NCT00006019
Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer treatment 2 completed NCT00303719
Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy No drug interventions treatment 2 terminated NCT01222819
SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients treatment 4 terminated NCT00112619
Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors treatment 1 terminated NCT00376519
Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases No drug interventions treatment 1 terminated NCT00597519
A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy No drug interventions treatment 2 completed NCT00558519
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia No drug interventions treatment 2 unknown_status NCT01520519
Phase 2 Study of the Combination of Bruton's Tyrosine Kinase Inhibitor PCI-32765 and Rituximab in High-Risk Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Patients treatment 2 completed NCT00003619
Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia treatment 1 / 2 completed NCT02568241
Interferon-α After DLI for the Prevention of Relapse No drug interventions prevention 1 / 2 unknown_status NCT01191541
Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL) treatment 4 completed NCT00844441
Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia No drug interventions health_services_research Not Available completed NCT01507441
Studying DNA in Samples From Younger Patients With Down Syndrome and Acute Myeloid Leukemia Treated on COG-AAML0431 Clinical Trial No drug interventions Not Available Not Available completed NCT00005641
Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation treatment 2 terminated NCT00003341
Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy supportive_care 3 completed NCT01584141
Study of Lymphoma in Asia No drug interventions Not Available Not Available completed NCT00134017
Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer treatment 2 completed NCT00608517
Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil No drug interventions treatment Not Available terminated NCT00049517
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia treatment 3 completed NCT00936117
Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia treatment 2 completed NCT01085617
Standard Chemotherapy With or Without Nelarabine or Rituximab in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia treatment 3 active_not_recruiting NCT00990717
Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies treatment 1 completed NCT00066417
Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia treatment 2 terminated NCT00579917
Behavioral Intervention For BMT/SCT Survivors No drug interventions Not Available Not Available completed NCT03974217
Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts treatment 1 recruiting NCT01010217
Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide treatment 2 completed NCT00003217
Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia treatment 1 completed NCT00858117
A Phase II Trial of Alemtuzumab and Rituximab in Patients With Previously Untreated CLL treatment 2 completed NCT00301834
Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders No drug interventions treatment 2 completed NCT00833534
Lenalidomide With or Without Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Undergone Autologous or Syngeneic Stem Cell Transplant treatment 2 withdrawn NCT01059734
S9031-S9126-S9333-S9500-B Biomarker Expression in Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00005634
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy treatment 1 completed NCT03876834
Respiratory Training in Patients With Leukemia No drug interventions treatment Not Available completed NCT00002534
Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission treatment 3 completed NCT04968834
Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens From Children And Young Adults With Hematologic Malignancy No drug interventions Not Available Not Available recruiting NCT00580034
Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath No drug interventions treatment 2 completed NCT00598624
Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) No drug interventions treatment 2 unknown_status NCT00001424
Evaluation and Natural History of Children With Cancer and AIDS No drug interventions Not Available Not Available completed NCT00324324
Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant No drug interventions supportive_care 3 terminated NCT00957424
Acceptability of Less Harmful Alternatives to Cigarettes Not Available Not Available completed NCT01035216
A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) No drug interventions treatment 1 terminated NCT00955916
CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML) treatment 2 completed NCT00002816
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia treatment 3 completed NCT00003816
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer treatment 2 / 3 completed NCT00075816
Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) No drug interventions treatment 3 completed NCT00070616
Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support treatment 1 completed NCT01378416
Pharmacokinetic Trial of Decitabine (Dacogen) Administered as a 3-hour Infusion to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome treatment 1 completed NCT00341016
Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident No drug interventions Not Available Not Available completed NCT00052416
Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia treatment 1 completed NCT00077116
Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome treatment 2 completed NCT00008216
Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer No drug interventions Not Available Not Available terminated NCT00498316
Cord Blood Expansion on Mesenchymal Stem Cells No drug interventions treatment 1 completed NCT01419496
Study of Proteins in Promoting Chemotherapy Resistance in Samples From Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT03677596
A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients treatment 4 completed NCT00003396
Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00005596
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia treatment 3 completed NCT00004896
Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome treatment 2 completed NCT00058396
Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma treatment 1 completed NCT02976558
The Influence of TaKeTiNa Music Therapy, Traditional Chinese Acupuncture and Clown Theatrical Performance on Quality of Life and the Therapeutic Process of Patients Undergoing Allogenic Stem Cell Transplantation No drug interventions treatment Not Available terminated NCT00002658
Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia treatment 3 unknown_status NCT02167958
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source treatment 1 completed NCT00003758
Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia treatment 2 unknown_status NCT04604158
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients No drug interventions supportive_care Not Available completed NCT04756258
Early Diagnosis of Leukemic Children Patients Based on Clinical, Age Estimation and Radiographical Evaluation of Oral Affection No drug interventions Not Available Not Available completed NCT00004058
12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder treatment 1 terminated NCT00110058
Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia treatment 2 completed NCT00077558
3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome treatment 1 completed NCT00004858
Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma treatment 1 unknown_status NCT00402558
Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) No drug interventions treatment 1 completed NCT00438958
Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases No drug interventions treatment 3 completed NCT00022035
Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia No drug interventions supportive_care Not Available completed NCT00993135
Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia Not Available Not Available completed NCT01575535
S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00402935
Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer No drug interventions Not Available Not Available withdrawn NCT00003435
Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer treatment 1 withdrawn NCT00096135
Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes treatment Not Available completed NCT01038635
5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) treatment 1 / 2 completed NCT01642563
Italian Platelet Technology Assessment Study No drug interventions supportive_care 3 terminated NCT01169363
Biomarkers in Bone Marrow and Blood Samples From Older Patients With Acute Myeloid Leukemia Treated With Cytarabine-Based Therapy No drug interventions Not Available Not Available completed NCT01164163
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease treatment 1 completed NCT00339963
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma No drug interventions Not Available Not Available completed NCT02530463
Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome treatment 2 active_not_recruiting NCT00579163
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers No drug interventions Not Available Not Available active_not_recruiting NCT00589563
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer No drug interventions supportive_care 2 completed NCT00004263
Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome treatment 1 completed NCT02305563
An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia treatment 1 / 2 terminated NCT00074763
Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets No drug interventions treatment 3 terminated NCT00852163
Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen treatment 2 completed NCT05237986
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy No drug interventions Not Available Not Available suspended NCT00005986
Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia treatment 2 terminated NCT04472286
Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors No drug interventions Not Available Not Available completed NCT01185886
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available unknown_status NCT00217386
Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes No drug interventions treatment 2 completed NCT01119586
Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT00049686
VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome treatment 1 completed NCT00452439
A Study of Actonel for the Prevention of Bone Loss No drug interventions treatment 3 completed NCT02028039
IPI-145 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL) treatment 2 withdrawn NCT00093639
Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate treatment 1 / 2 completed NCT02546739
Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL No drug interventions treatment 1 unknown_status NCT00609739
Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation No drug interventions treatment 1 / 2 terminated NCT00004239
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment treatment 1 terminated NCT00551239
Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma No drug interventions treatment 3 withdrawn NCT02663622
Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002) treatment 2 completed NCT01401322
Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia treatment 2 terminated NCT00376922
Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases No drug interventions supportive_care Not Available completed NCT01649622
Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL) treatment 2 withdrawn NCT00077922
Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia No drug interventions treatment 2 completed NCT00006225
Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer treatment 1 / 2 completed NCT02280525
Cord Blood Natural Killer (NK) Cells in Leukemia/Lymphoma treatment 1 completed NCT01137825
Registry of Older Patients With Cancer No drug interventions Not Available Not Available recruiting NCT01720225
Decitabine Versus Azacitidine in Myelodysplastic Syndrome Patients With Low and Intermediate-1 Risk treatment 2 completed NCT00003425
Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect treatment 1 / 2 completed NCT00919425
S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer No drug interventions Not Available Not Available completed NCT01360125
S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy No drug interventions Not Available Not Available completed NCT00080925
T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies treatment 1 completed NCT00087425
Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia treatment 2 completed NCT00641030
Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes No drug interventions treatment 1 completed NCT00521430
Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease No drug interventions treatment Not Available completed NCT03434730
Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation treatment 2 active_not_recruiting NCT00046930
Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia treatment 3 completed NCT00039130
Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia treatment 2 completed NCT05690230
Improving Patient Experience: BMBA No drug interventions supportive_care Not Available active_not_recruiting NCT00555048
Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer No drug interventions treatment 1 / 2 terminated NCT00003148
Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia treatment 2 completed NCT00458848
Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia No drug interventions treatment 2 completed NCT00003248
Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic Leukemia treatment 2 completed NCT00022048
Bevacizumab in Treating Patients With Myelodysplastic Syndrome treatment 1 / 2 completed NCT00005948
Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia treatment 2 completed NCT00656448
A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS No drug interventions supportive_care 3 completed NCT00006348
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment supportive_care 3 completed NCT00323557
Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients No drug interventions treatment 2 completed NCT00613457
Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia No drug interventions treatment 3 completed NCT00448357
Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen No drug interventions treatment 1 / 2 completed NCT00415857
Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R) No drug interventions treatment 2 terminated NCT00967057
Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia treatment 3 completed NCT00038857
Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases treatment 2 completed NCT00005626
Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11) treatment 2 completed NCT00466726
Vaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia No drug interventions treatment 2 completed NCT06095726
Peppermint Inhalation Versus Swedish Massage on Chemotherapy Induced-Nausea and Vomiting in Children With Leukemia No drug interventions supportive_care Not Available completed NCT00118326
Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease treatment 1 / 2 completed NCT06537726
Breath Analysis for the Detection of Invasive Fungal Infections No drug interventions Not Available Not Available not_yet_recruiting NCT03404726
A Study to Investigate BAY2402234, a Dihydroorotate Dehydrogenase (DHODH) Inhibitor, in Myeloid Malignancies No drug interventions treatment 1 terminated NCT01300026
AMG 319 Lymphoid Malignancy FIH No drug interventions treatment 1 completed NCT00423826
Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease No drug interventions Not Available Not Available no_longer_available NCT00345826
Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia No drug interventions treatment 1 completed NCT01752426
Pilot Study to Determine Effects of the Btk Inhibitor PCI-32765 on Leukemia Cell Kinetics and Trafficking, Using Heavy Water Labeling in Subjects With CLL and SLL treatment 1 / 2 completed NCT04504526
Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases No drug interventions diagnostic 0 recruiting NCT00626626
Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation No drug interventions treatment 1 / 2 terminated NCT00002926
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia treatment 3 unknown_status NCT00660166
Human Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell Infusions No drug interventions treatment 1 completed NCT00362466
A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy No drug interventions treatment 3 terminated NCT05635266
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives No drug interventions Not Available Not Available recruiting NCT00544466
Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies No drug interventions treatment 1 / 2 active_not_recruiting NCT00002766
Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma treatment 3 completed NCT00005866
S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia treatment 3 completed NCT00002765
Immunotoxin in Treating Patients With Leukemia or Lymphoma No drug interventions treatment 1 completed NCT00004065
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer treatment 1 completed NCT02505165
Illness Management and Parental Adjustment to Cancer Treatment No drug interventions supportive_care Not Available completed NCT00630565
Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia No drug interventions treatment 2 / 3 terminated NCT02210065
Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation No drug interventions treatment 2 completed NCT05743465
A Study to Evaluate Available Treatment Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and Nilotinib in Adults With Chronic Myeloid Leukemia No drug interventions Not Available Not Available completed NCT02796365
Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy No drug interventions prevention Not Available completed NCT03452774
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry No drug interventions Not Available Not Available recruiting NCT02225574
An Open-Label, Phase I/II Study of Nilotinib (Tasigna) and MEK-162 (ARRY-162) Used in Combination for Patients With Refractory or Advanced Chronic Myeloid Leukemia and Philadelphia Positive Acute Leukemia (Protocol CAMN107AUS41T) treatment 1 terminated NCT01225874
Biomarkers to Classify Young Patients With Acute Lymphoblastic Leukemia (ALL) and Remission Induction Therapy in Young Patients With B-Precursor ALL treatment Not Available completed NCT00963274
Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma treatment 1 completed NCT02194374
Autologous ROR1R-CAR-T Cells for Chronic Lymphocytic Leukemia (CLL) treatment 1 withdrawn NCT00002674
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia treatment 2 completed NCT00002574
Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia treatment 2 completed NCT00900120
Collecting and Storing Blood Samples From Patients With Cancer No drug interventions Not Available Not Available withdrawn NCT01139320
Biomarkers in DNA Samples From Younger Patients With Newly Diagnosed Acute Myeloid Leukemia Receiving Gemtuzumab Ozogamicin No drug interventions Not Available Not Available completed NCT01249820
Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease other 2 completed NCT01893320
Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome treatment 1 / 2 completed NCT00078520
Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells No drug interventions treatment 1 completed NCT00006020
S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia treatment 2 completed NCT02345382
Phase I Dose Escalation of BAY1143572 in Subjects With Acute Leukemia No drug interventions treatment 1 completed NCT00074282
Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL treatment 2 completed NCT00003082
Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer No drug interventions treatment 1 completed NCT00062231
Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer supportive_care Not Available terminated NCT00002531
Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia treatment 2 unknown_status NCT03862131
PROactive Evaluation of Function to Avoid CardioToxicity No drug interventions supportive_care 2 terminated NCT00058331
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors supportive_care 3 completed NCT00002831
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia treatment 1 / 2 completed NCT01656031
A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia treatment 2 completed NCT00185731
Phase 2 Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma treatment 2 completed NCT00003131
CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse treatment 2 completed NCT01162031
Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia treatment 2 withdrawn NCT02942173
CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT No drug interventions prevention 2 / 3 completed NCT00446173
Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia No drug interventions treatment 2 withdrawn NCT00080873
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation No drug interventions supportive_care Not Available completed NCT06522373
Phase I Trial of MT-0169 in CD38+ Acute Leukemia With Relapsed/Refractory or Measurable Residual Disease treatment 1 not_yet_recruiting NCT00386373
Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients No drug interventions treatment Not Available completed NCT00015873
Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia treatment 3 completed NCT00020527
Caspofungin Acetate in Treating Children With Fever and Neutropenia supportive_care Not Available completed NCT00899327
Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants No drug interventions Not Available Not Available unknown_status NCT00003727
Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia treatment 2 completed NCT00237627
Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer No drug interventions treatment 1 / 2 completed NCT00809276
Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY treatment 1 / 2 completed NCT00354276
VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia No drug interventions treatment 2 unknown_status NCT00882076
Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias treatment 1 terminated NCT00274976
Alemtuzumab in Treating Patients With Advanced Chronic Lymphocytic Leukemia That Did Not Respond to Previous Fludarabine No drug interventions treatment 2 completed NCT00064376
Paricalcitol in Treating Patients With Myelodysplastic Syndrome treatment 2 completed NCT01971476
Open Dose Escalating Trial to Determine the Maximum Tolerated Dose in Paediatric Patients With Advanced Cancers for Whom no Therapy is Known treatment 1 completed NCT00551460
S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia No drug interventions treatment 2 completed NCT00003960
Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00507260
Nutritional Assessment Intervention to Improve Cancer-Related Fatigue No drug interventions treatment Not Available completed NCT00391560
Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia No drug interventions treatment 2 completed NCT00015860
STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia treatment 1 / 2 completed NCT00001560
Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers No drug interventions Not Available Not Available completed NCT00027560
Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer treatment 2 completed NCT01253460
Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23) treatment 2 terminated NCT00512460
RTA 744 Injection in Patients With Leptomeningeal Disease No drug interventions treatment 1 terminated NCT00014560
Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia treatment 1 terminated NCT00353860
Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances No drug interventions treatment 2 completed NCT00383994
Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation No drug interventions treatment 1 completed NCT03583294
A Study on the Uterus, Ovarian and Reproductive Functions According to Conditioning Regimen and Pubertal Status at the Time of Stem Cell Transplantation in a Leukemia Pediatric Population No drug interventions prevention Not Available unknown_status NCT00577694
Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia No drug interventions treatment 1 terminated NCT02723994
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia treatment 2 active_not_recruiting NCT00324194
A Phase I Study of MGCD0103 Given Twice Weekly in Patients With Leukemia or Myelodysplastic Syndromes No drug interventions treatment 1 completed NCT04014894
ET019003-T Cells in Relapsed/Refractory CD19+ B-Cell Leukemia and Lymphoma No drug interventions treatment 1 unknown_status NCT00003291
Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT03330691
A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia No drug interventions treatment 1 active_not_recruiting NCT05886491
A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia treatment 1 / 2 recruiting NCT00601991
A Multi-Center Phase 2 Study of VEGF Trap as a Single Agent in Acute Myeloid Leukemia No drug interventions treatment 2 withdrawn NCT00000591
T-Cell Depletion in Unrelated Donor Marrow Transplantation No drug interventions treatment 3 completed NCT00422591
Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML) No drug interventions treatment 2 completed NCT00369291
CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant No drug interventions treatment 1 terminated NCT00427791
Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic Leukemia No drug interventions treatment 2 completed NCT00006091
Arsenic Trioxide in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Has Not Responded to Previous Treatment treatment 2 withdrawn NCT00003962
Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer treatment 1 completed NCT00006462
Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia treatment 2 completed NCT00004862
Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia treatment 1 completed NCT01572662
Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning treatment 2 completed NCT00025662
Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS No drug interventions treatment 2 completed NCT00725062
Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant No drug interventions treatment 1 terminated NCT00295880
Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer No drug interventions treatment 1 / 2 terminated NCT00774280
Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen treatment 3 completed NCT00987480
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine treatment 2 completed NCT02269280
Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) treatment 2 completed NCT04896580
IIT2020-20-SHIRAZIP-WALK: Nature Walks No drug interventions supportive_care Not Available active_not_recruiting NCT00031980
Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer supportive_care 2 completed NCT01222780
To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer treatment 1 completed NCT02755480
Ultralow Dose Thoracic Computed Tomography in Immunocompromised Patients No drug interventions diagnostic Not Available terminated NCT05794880
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing No drug interventions treatment Not Available recruiting NCT01607580
Efficacy Study of Low-dose Glucocorticoid Prophylaxis for Acute Graft-versus-host Disease(GVHD) prevention Not Available completed NCT01434329
S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00244829
Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia No drug interventions treatment 1 / 2 completed NCT00005829
Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia treatment 2 completed NCT00324129
A Phase I Study of MGCD0103 Given Three-Times Weekly In Patients With Leukemia Or Myelodysplastic Syndromes No drug interventions treatment 1 completed NCT03770429
AZD6738 for Patients With Progressive MDS or CMML treatment 1 recruiting NCT00179829
WT1 for the Detection of Minimal Residual Disease No drug interventions treatment 2 / 3 completed NCT00625729
Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia No drug interventions treatment 1 / 2 terminated NCT00002989
Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome treatment 3 unknown_status NCT00002789
Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia treatment 3 completed NCT00514189
Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines No drug interventions treatment 1 terminated NCT01728389
Intrabone Transplantation of Allogenic Peripheral Blood Stem Cells in Patients With Myeloid and Lymphoid Malignancies. No drug interventions treatment 1 / 2 unknown_status NCT03684889
CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma No drug interventions treatment 1 active_not_recruiting NCT00017589
Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia treatment 2 completed NCT00003289
UCN-01 in Treating Patients With Advanced Cancer treatment 1 completed NCT00001689
A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia treatment 1 completed NCT00554489
Physical Activity in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy No drug interventions supportive_care Not Available completed NCT03826992
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia No drug interventions treatment 1 recruiting NCT00943592
Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies No drug interventions treatment 1 / 2 completed NCT00002792
Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders treatment 2 completed NCT01034592
Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia No drug interventions treatment 1 terminated NCT04310592
Natural Killer Cell (CYNK-001) Infusions in Adults With AML No drug interventions treatment 1 recruiting NCT01915992
Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies No drug interventions Not Available Not Available unknown_status NCT00069992
Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML treatment 2 terminated NCT00005092
Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 1 completed NCT00515892
Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease No drug interventions treatment 1 unknown_status NCT05425992
Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families No drug interventions Not Available Not Available recruiting NCT00550992
Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia No drug interventions treatment Not Available unknown_status NCT01096992
Fludarabine, Bendamustine, and Rituximab (FBR) for Relapsed Chronic Lymphocytic Leukemia (CLL) No drug interventions treatment 1 / 2 completed NCT00709592
Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT No drug interventions treatment 2 completed NCT00124644
Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia treatment 1 terminated NCT00701844
Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors No drug interventions treatment Not Available completed NCT00002744
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia treatment 3 completed NCT00096044
Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia treatment 2 completed NCT00053144
Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia treatment 1 completed NCT05046444
Solving Riddles Through Sequencing No drug interventions Not Available Not Available recruiting NCT00458744
Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment No drug interventions treatment 1 withdrawn NCT02829840
Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML) No drug interventions treatment 1 / 2 withdrawn NCT00185640
Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies No drug interventions treatment 2 completed NCT00024440
Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia treatment 3 completed NCT00417040
Collection of Patient-Reported Symptoms and Performance Status Via the Internet No drug interventions other Not Available completed NCT00643240
Yttrium Y 90 Anti-CD19 Antibody BU-12 in Patients With Advanced Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Lymphocytic Leukemia No drug interventions treatment 1 terminated NCT00006340
Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus treatment 1 completed NCT00838240
Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia No drug interventions treatment 1 / 2 unknown_status NCT00006240
Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia treatment 2 completed NCT00003840
DTGM Fusion Protein in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia No drug interventions treatment 1 / 2 completed NCT01004640
Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial No drug interventions Not Available Not Available active_not_recruiting NCT00914940
Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD No drug interventions treatment 2 terminated NCT00004040
Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy treatment 2 withdrawn NCT00006040
Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia treatment 1 completed NCT00082940
Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia treatment 2 completed NCT02638467
Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy No drug interventions treatment 2 completed NCT00483067
2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES) No drug interventions treatment 2 completed NCT00897767
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial No drug interventions Not Available Not Available completed NCT00806767
Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer No drug interventions treatment 2 completed NCT00299767
Phase I Study of Sequential Cord Blood Transplants No drug interventions treatment 1 completed NCT00002567
High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission treatment 2 completed NCT00896701
Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2 No drug interventions Not Available Not Available completed NCT04497701
Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Malignancies No drug interventions prevention Not Available unknown_status NCT00276601
Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia No drug interventions treatment 2 completed NCT04961801
Acalabrutinib for GVHD Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation in Lymphomas and Leukemia No drug interventions treatment 1 / 2 withdrawn NCT05793801
Study of the Impact of Frequency of Changing PICCline Dressings in Patients With Acute Leukemia No drug interventions prevention Not Available recruiting NCT00088101
STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors No drug interventions treatment 1 completed NCT00281801
Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation No drug interventions Not Available Not Available completed NCT00002704
Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia treatment 2 completed NCT00134004
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer treatment 2 completed NCT00436904
Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic Leukemia No drug interventions treatment 2 completed NCT05168904
A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS) No drug interventions treatment 1 / 2 suspended NCT00005804
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00973804
Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders No drug interventions treatment 1 terminated NCT00780104
Sirolimus in Combination With MEC in High Risk Myeloid Leukemias No drug interventions treatment 1 completed NCT00002504
Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer treatment 2 completed NCT00634504
Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze No drug interventions treatment 1 completed NCT01455272
New Therapy for Advanced Stage Leukemia After Stem Cell Transplantation No drug interventions prevention Not Available completed NCT00354172
Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers. No drug interventions treatment 2 terminated NCT00003268
Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia treatment 1 completed NCT05544968
CD30biAb-AATC for CD30+ Malignancies No drug interventions treatment 1 / 2 not_yet_recruiting NCT00335868
PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy No drug interventions treatment 2 unknown_status NCT00900068
Blood Samples From Patients on a Clinical Trial to CINV During HSCT No drug interventions Not Available Not Available terminated NCT00365768
Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors No drug interventions supportive_care 2 completed NCT01005368
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia No drug interventions Not Available Not Available completed NCT00887068
Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129) No drug interventions treatment 3 completed NCT06296368
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics No drug interventions health_services_research Not Available not_yet_recruiting NCT00003868
Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia treatment 2 completed NCT00898469
Identifying Risk Factors for Bone Tissue Death in Young Patients With Acute Lymphoblastic Leukemia Treated on Clinical Trial CCG-1882 No drug interventions Not Available Not Available completed NCT00020969
Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes treatment 2 terminated NCT00343369
Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia No drug interventions treatment Not Available unknown_status NCT01018069
AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen No drug interventions treatment 2 terminated NCT00014469
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer treatment 2 completed NCT00534469
Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R No drug interventions treatment 2 active_not_recruiting NCT06026046
Feasibility of an Adapted Sports Program Based on Fencing to Reduce Physical Deconditioning in Adult Hematology Patients No drug interventions supportive_care Not Available recruiting NCT03142646
Safety and Efficacy Evaluation of IM19 CAR-T Cells No drug interventions treatment 1 / 2 unknown_status NCT01615146
Outpatient Platelet Transfusions in Myelodysplastic Syndromes and Leukemia: The OPTIMAL Pilot No drug interventions treatment Not Available terminated NCT03281746
Effect of Prevention Education in Caries Formation in Pediatric Patients With Leukemia No drug interventions prevention Not Available terminated NCT00006246
Busulfan in Treating Children and Adolescents With Refractory CNS Cancer treatment 1 completed NCT00801346
Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission No drug interventions Not Available Not Available completed NCT02302846
Study of MLN9708 as Maintenance Therapy for Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) in Remission No drug interventions treatment 2 terminated NCT00581646
Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance No drug interventions Not Available Not Available completed NCT00400946
Treatment of Acute Lymphoblastic Leukemia in Children No drug interventions treatment 3 completed NCT00048412
Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H treatment 1 / 2 completed NCT00002912
Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia treatment 1 completed NCT00756912
A Study of Eritoran (E5564) Administered IV Over 14 Days Prior to and During Bone Marrow Engraftment in BMT Patients Who Have Received Myeloablative Conditioning Treatment and Are Receiving Bone Marrow or Stem Cells From Matched Related Donors No drug interventions prevention 1 terminated NCT04541212
Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia No drug interventions Not Available Not Available recruiting NCT00301912
Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer No drug interventions treatment 2 withdrawn NCT00564512
Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP No drug interventions treatment 3 completed NCT00038610
Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia treatment 2 completed NCT02642510
Improving Patient Education for Lymphoma and Leukemia Inpatients No drug interventions other Not Available completed NCT02958410
A Clinical Research of CD30-Targeted CAR-T in Lymphocyte Malignancies No drug interventions treatment 1 / 2 unknown_status NCT02403310
A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML No drug interventions treatment 1 completed NCT00293410
Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders No drug interventions treatment 1 completed NCT01284010
Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT00075010
Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes treatment 1 / 2 completed NCT00429910
Natural History Study of Patients With Chronic Myelogenous Leukemia No drug interventions Not Available Not Available completed NCT00255710
Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer No drug interventions supportive_care 1 completed NCT05366881
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease No drug interventions Not Available Not Available recruiting NCT01319981
Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia No drug interventions treatment 2 completed NCT00274781
Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes No drug interventions treatment 2 completed NCT00350181
Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT No drug interventions treatment 2 completed NCT02743481
Early Life Exposures in Agriculture No drug interventions Not Available Not Available completed NCT00411281
Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder No drug interventions treatment 3 withdrawn NCT00419081
Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens No drug interventions treatment 2 terminated NCT00493181
Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) Patients No drug interventions treatment 2 completed NCT00186381
Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission No drug interventions treatment 2 completed NCT00004181
Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia treatment 2 completed NCT06250595
European Rare Blood Disorders Platform (ENROL) No drug interventions Not Available Not Available recruiting NCT00816595
Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma No drug interventions treatment 2 completed NCT00084695
Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases treatment 2 unknown_status NCT00005795
Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia treatment 2 completed NCT00014495
Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer treatment 1 / 2 completed NCT00904995
Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis No drug interventions treatment 3 completed NCT00003395
Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer treatment 1 completed NCT00752895
American Ginseng Extract in Preventing Respiratory Infection and in Reducing Antibiotic Use in Patients With CLL No drug interventions prevention 2 completed NCT01222195
Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS) No drug interventions treatment 2 terminated NCT00004114
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer treatment 1 withdrawn NCT00002514
Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission treatment 3 completed NCT01126814
A Study of Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia No drug interventions treatment 1 / 2 completed NCT00004255
Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation treatment 2 / 3 completed NCT00030355
Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia treatment 1 / 2 withdrawn NCT04187755
Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever No drug interventions treatment 4 completed NCT00060255
High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors treatment 2 completed NCT00081055
OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies supportive_care 2 withdrawn NCT00898755
Collecting and Storing Tissue From Young Patients With Cancer No drug interventions Not Available Not Available active_not_recruiting NCT00003255
Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia treatment 2 completed NCT01639950
Validating Pain Scales in Children and Young Adults No drug interventions Not Available Not Available completed NCT00024050
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome treatment 2 completed NCT04847050
A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy No drug interventions prevention 2 completed NCT02748850
Evaluation of the Effectiveness of an Aldehyde Inhibitor Dehydrogenases (DIMATE) on the Cell Population Leukemic or Normal Stem No drug interventions basic_science Not Available unknown_status NCT00089050
Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia treatment 2 completed NCT00030550
Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome treatment 2 completed NCT00296023
Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer No drug interventions treatment Not Available completed NCT00068523
Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies treatment Not Available completed NCT00001623
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia No drug interventions treatment Not Available completed NCT02473523
Yoga to Alleviate Fatigue, Anxiety and Pain in Adolescents During Treatment for Lymphoma or Leukemia No drug interventions supportive_care Not Available terminated NCT00107523
Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia treatment 1 completed NCT00003408
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer treatment 2 completed NCT00365508
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking No drug interventions treatment 4 completed NCT00387608
ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer No drug interventions treatment 1 completed NCT05691608
MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2 No drug interventions diagnostic Not Available recruiting NCT00305708
Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission No drug interventions treatment 1 / 2 completed NCT00968838
A Study for Leukemia Patients With Life-Threatening Infections No drug interventions treatment 3 completed NCT00002738
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma treatment 2 completed NCT02420938
Urelumab (CD137 mAb) With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients No drug interventions treatment 2 withdrawn NCT00943943
Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations No drug interventions treatment 1 completed NCT00819143
Collection of Blood and Bone Marrow Samples From Select Patients With CML to Measure Minimal Residual Disease No drug interventions Not Available Not Available completed NCT01786343
Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML) No drug interventions treatment 2 completed NCT01207843
Optimized Radiological Diagnosis of Hepatic Candidiasis During the Treatment of Acute Leukemias No drug interventions Not Available Not Available completed NCT00006343
STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia treatment 3 completed NCT00005603
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia treatment 3 completed NCT05268003
A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia No drug interventions treatment 2 recruiting NCT00003003
Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia treatment 1 completed NCT05808803
Aberrant Myeloid Lineage Differentiation in HIV/AIDS Patients No drug interventions Not Available Not Available completed NCT00516503
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer No drug interventions supportive_care 3 completed NCT00723203
Panobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia No drug interventions treatment 2 terminated NCT00714103
8-Chloro-Adenosine in Chronic Lymphocytic Leukemia No drug interventions treatment 1 completed NCT00075803
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) treatment 3 completed NCT00121303
Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes treatment 3 completed NCT02441803
Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) No drug interventions treatment 2 completed NCT02937103
A Clinical Research of CD123-Targeted CAR-T in Myeloid Malignancies No drug interventions treatment 1 / 2 unknown_status NCT01214603
A Study in Participants With Acute Leukemia No drug interventions treatment 2 completed NCT00022490
Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia treatment 2 terminated NCT04898790
Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant No drug interventions treatment Not Available recruiting NCT00006090
Arsenic Trioxide in Treating Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia treatment 2 withdrawn NCT00064090
3-AP and Cytarabine in Treating Patients With Hematologic Cancer treatment 1 completed NCT00665990
Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia No drug interventions treatment 1 completed NCT00040690
Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia treatment 2 completed NCT00036790
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer treatment 1 completed NCT01016990
Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia No drug interventions treatment 2 unknown_status NCT00382590
Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients No drug interventions treatment 2 completed NCT00006390
Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia treatment 2 completed NCT00074490
Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers treatment 2 terminated NCT00008164
Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia No drug interventions treatment 2 unknown_status NCT00003764
Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia treatment 3 completed NCT00369564
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer No drug interventions supportive_care 3 completed NCT00647764
Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas No drug interventions treatment 1 completed NCT00963521
Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia in Complete Remission No drug interventions treatment 1 completed NCT02719821
Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation No drug interventions supportive_care Not Available completed NCT00002621
Interferon Alfa in Treating Children With HIV-Related Cancer treatment 2 completed NCT00460421
A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT No drug interventions prevention 1 completed NCT00070421
Study of @neWorld: A Virtual Community for Children With Cancer No drug interventions Not Available 1 / 2 completed NCT05969821
Clonal Hematopoiesis of Immunological Significance No drug interventions Not Available Not Available not_yet_recruiting NCT00582621
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders No drug interventions Not Available Not Available recruiting NCT00025402
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia treatment 3 unknown_status NCT01794702
Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia No drug interventions treatment 1 / 2 completed NCT00425802
Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia No drug interventions treatment 2 completed NCT00003402
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia treatment 2 completed NCT00871702
Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease No drug interventions treatment 1 completed NCT01099202
Procrit Versus No Procrit in Acute Lymphocytic Leukemia, Lymphoblastic Lymphoma, or Burkitt's Undergoing Induction/Consolidation Chemotherapy No drug interventions treatment Not Available completed NCT02273102
Study of TCP-ATRA for Adult Patients With AML and MDS No drug interventions treatment 1 completed NCT00306202
Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia No drug interventions treatment 1 completed NCT00553202
Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia No drug interventions treatment 2 completed NCT00665002
Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms No drug interventions treatment Not Available completed NCT00003602
Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia treatment 3 unknown_status NCT00892502
Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy? No drug interventions treatment Not Available completed NCT00840684
Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia No drug interventions treatment 1 / 2 completed NCT00416884
Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML No drug interventions treatment 2 terminated NCT01247584
Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00034684
Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701) No drug interventions treatment 1 / 2 completed NCT00143884
Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood No drug interventions educational_counseling_training 2 terminated NCT00006084
Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia treatment 2 unknown_status NCT02730884
Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia No drug interventions treatment 2 terminated NCT03759184
Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia No drug interventions treatment 1 terminated NCT02043184
Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR No drug interventions supportive_care Not Available completed NCT01138579
Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation No drug interventions treatment 1 / 2 withdrawn NCT00101179
MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia treatment 1 completed NCT00038779
Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States No drug interventions treatment Not Available terminated NCT01016379
Studying DNA in Blood and Bone Marrow Samples From Young Patients With Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT00324779
Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia No drug interventions treatment 2 completed NCT00003079
Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma treatment 1 completed NCT00281879
Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer No drug interventions treatment 2 terminated NCT00397579
DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes No drug interventions treatment 1 / 2 completed NCT00006379
Non-Ablative Allo HSCT For Hematologic Malignancies or SAA treatment 2 completed NCT00313079
Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia No drug interventions treatment 1 completed NCT00072579
Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment treatment 2 completed NCT02872987
GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial No drug interventions Not Available Not Available recruiting NCT00480987
Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS) No drug interventions treatment 1 / 2 terminated NCT05064787
Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy No drug interventions supportive_care Not Available completed NCT00376987
Zinc Supplements in Lowering Cadmium Levels in Smokers No drug interventions prevention 2 completed NCT05528887
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies No drug interventions treatment 1 recruiting NCT06138587
Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation No drug interventions treatment 1 recruiting NCT00462787
Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia No drug interventions treatment 1 completed NCT00003187
Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma treatment 2 / 3 completed NCT00083187
VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia treatment 2 completed NCT00081133
Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia treatment 1 / 2 completed NCT01258933
Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy No drug interventions treatment 2 active_not_recruiting NCT00568633
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML No drug interventions treatment 3 terminated NCT00195533
Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients No drug interventions Not Available Not Available completed NCT01500733
PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma No drug interventions treatment 2 active_not_recruiting NCT01446133
Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL) No drug interventions treatment 2 active_not_recruiting NCT00002833
Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia treatment 2 completed NCT00064233
BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate treatment 1 completed NCT00003933
Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia No drug interventions diagnostic Not Available completed NCT00482833
Phase III Trial in Acute Promyelocytic Leukemia Patients No drug interventions treatment 3 completed NCT00587054
Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders No drug interventions treatment 2 completed NCT06275854
YASU Research Registry: For Young Adults With Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT03057054
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant No drug interventions prevention 3 active_not_recruiting NCT01049854
CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant No drug interventions treatment 2 completed NCT02065154
Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis No drug interventions prevention 2 completed NCT00112554
Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia No drug interventions treatment 3 completed NCT00001251
Phase I Study of Intrathecal Mafosfamide treatment 1 completed NCT00003451
Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer treatment 1 completed NCT00021151
Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia treatment Not Available completed NCT00611351
Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer No drug interventions treatment 2 completed NCT00022451
Tipifarnib in Treating Young Patients With Refractory Leukemia treatment 1 completed NCT00968253
RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia No drug interventions treatment 1 / 2 completed NCT00002553
Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer treatment 2 completed NCT00005853
Biological Therapy in Treating Patients With Myelodysplastic Syndrome treatment 2 completed NCT00055653
Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders treatment 2 completed NCT02356653
Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC No drug interventions treatment 0 recruiting NCT00003077
Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss No drug interventions supportive_care 1 / 2 completed NCT06335277
Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology No drug interventions Not Available Not Available recruiting NCT04593277
Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study No drug interventions supportive_care Not Available recruiting NCT00792077
A Pilot Study to Investigate the Effect of Cytotoxic Therapy and/or Radiotherapy on Cancer Related Sleep Disturbances in CLL and Breast Cancer Patients Experiencing Fatigue No drug interventions treatment 2 completed NCT05403177
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) No drug interventions Not Available Not Available recruiting NCT00387647
Maintenance Azacitidine in Elderly Patients With Acute Myeloid Leukemia (AML) in CR After Induction Chemotherapy No drug interventions treatment 2 completed NCT00996047
S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers No drug interventions Not Available Not Available completed NCT00343447
Cyclophosphamide and Rituximab Followed By Vaccine Therapy in Treating Patients With Chronic Lymphocytic Leukemia No drug interventions treatment 2 withdrawn NCT00028847
Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia treatment 1 / 2 unknown_status NCT05061147
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) No drug interventions treatment 1 / 2 unknown_status NCT02656147
Immunotherapy With CD19 CAR γδT-cells for B-Cell Lymphoma, ALL and CLL No drug interventions treatment 1 unknown_status NCT01517347
Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation No drug interventions prevention Not Available terminated NCT00002547
Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome treatment 2 completed NCT06487247
HEME Home Transfusion Program No drug interventions supportive_care Not Available not_yet_recruiting NCT00548847
Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation No drug interventions treatment 2 completed NCT02954445
A Clinical Research of BCMA-Targeted CAR-T in B Cell Malignancies No drug interventions treatment 1 / 2 unknown_status NCT00004145
Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00782145
A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families No drug interventions supportive_care 3 completed NCT00619645
Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers No drug interventions treatment 2 completed NCT00006045
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia treatment 3 unknown_status NCT00004245
Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia treatment 1 completed NCT01629745
Genetic Test in Detecting Minimal Residual Disease in Samples From Younger Patients Registered on the COG-AALL08B1 Trial No drug interventions Not Available Not Available completed NCT00002598
Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia treatment 2 completed NCT00844298
Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia No drug interventions treatment 2 completed NCT06353698
Fasting Mimicking Diet With Chemotherapy in Patients With Leukemia No drug interventions treatment Not Available recruiting NCT02349698
A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma No drug interventions treatment 1 / 2 unknown_status NCT00759798
Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL) No drug interventions treatment 2 completed NCT00006098
PS-341 in Treating Patients With Hematologic Cancer treatment 1 completed NCT00488605
H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis No drug interventions treatment 3 withdrawn NCT03801005
Immunophenotyping of Blast Cells and Immune Effector Cells in Peripheral Whole Blood and Bone Marrow Samples From AML and MDS Patients (AML) No drug interventions Not Available Not Available completed NCT00057005
Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation treatment 1 completed NCT00304005
VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders No drug interventions treatment 1 / 2 completed NCT00002805
Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome treatment 2 completed NCT00004105
Combination Chemotherapy in Treating Patients With Advanced Cancer treatment 1 / 2 completed NCT01046305
Symptom Burden in Chronic Myeloid Leukemia (CML) No drug interventions Not Available Not Available unknown_status NCT00002705
Topotecan in Treating Children With Refractory Leukemia treatment 1 completed NCT00038805
Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS) treatment 2 / 3 terminated NCT00004905
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia treatment 2 completed NCT00003405
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia treatment 2 withdrawn NCT00008697
Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia treatment 1 / 2 completed NCT00607997
Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia No drug interventions treatment 2 completed NCT01108497
Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia No drug interventions Not Available Not Available terminated NCT00295997
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia No drug interventions treatment Not Available unknown_status NCT01220297
Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT No drug interventions treatment 2 terminated NCT00893997
PR1 Vaccination in Myelodysplastic Syndrome (MDS) No drug interventions treatment 2 terminated NCT00100997
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate treatment 1 completed NCT02481297
Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients No drug interventions treatment 2 completed NCT03144583
Pilot Study on the Infusion of ARI-0001 Cells in Patients With CD19+ Leukemia or Lymphoma Refractory to Therapy No drug interventions other 1 completed NCT04813783
The Effect of Mucositis Care Training Given to Caregivers in Pediatric Leukemia Cases on Mucosal Barrier Damage No drug interventions Not Available Not Available completed NCT02559583
Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America No drug interventions Not Available Not Available completed NCT00006083
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter supportive_care 3 completed NCT01156883
Combination Chemotherapy in Treating Young Adult Patients With Acute Lymphoblastic Leukemia No drug interventions treatment Not Available completed NCT00021983
Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia No drug interventions treatment 1 completed NCT00003783
Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia treatment 2 completed NCT00010283
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon supportive_care 1 / 2 completed NCT02910583
Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL) No drug interventions treatment 2 completed NCT00968461
Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders No drug interventions treatment 1 withdrawn NCT00002761
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia treatment 1 / 2 withdrawn NCT00787761
Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer No drug interventions treatment 2 completed NCT00278161
Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma No drug interventions treatment 2 completed NCT06177561
Safety and Efficacy of LPE in Clearing DSA in Patients Who Received Allo-HSCT No drug interventions treatment Not Available recruiting NCT02784561
Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation No drug interventions treatment 4 unknown_status NCT00002961
Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia treatment 3 terminated NCT00651261
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia No drug interventions treatment 3 unknown_status NCT01983761
Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation No drug interventions treatment 1 / 2 unknown_status NCT02185261
Interferon α for the Therapy of Minimal Residual Disease No drug interventions treatment Not Available unknown_status NCT00003961
Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome treatment 2 completed NCT00462761
A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status No drug interventions treatment 1 completed NCT00516828
Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome No drug interventions treatment 1 / 2 completed NCT01581528
Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT00113828
Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies No drug interventions treatment 2 terminated NCT00004128
Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia treatment 3 unknown_status NCT00290628
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer No drug interventions treatment Not Available terminated NCT00003728
Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma treatment 3 unknown_status NCT00939328
S0902 Bendamustine and Rituximab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Not Responded to Previous Treatment No drug interventions treatment 2 withdrawn NCT00941928
Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL) No drug interventions treatment 2 terminated NCT01551628
A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma No drug interventions treatment 1 terminated NCT00562328
Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia No drug interventions treatment 2 completed NCT02360111
GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant No drug interventions treatment Not Available terminated NCT00666211
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain No drug interventions supportive_care 3 completed NCT00716911
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant No drug interventions supportive_care Not Available completed NCT00020111
Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma treatment 1 completed NCT00003693
Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia treatment 1 completed NCT03873493
A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia No drug interventions treatment 2 completed NCT00005793
A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide treatment 1 / 2 completed NCT00301093
Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia No drug interventions treatment 1 completed NCT00509093
Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy No drug interventions treatment 2 completed NCT00005593
Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome treatment 1 completed NCT02652871
LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia No drug interventions treatment 1 completed NCT00002471
Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma treatment 2 completed NCT00002771
Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia treatment 3 unknown_status NCT00003671
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia treatment 2 completed NCT00004871
Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome treatment 1 completed NCT00003171
Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome treatment 2 completed NCT00899171
S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT05649371
Multiphasic Prehab Allo-HSCT No drug interventions prevention Not Available not_yet_recruiting NCT00100971
Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia No drug interventions treatment 1 terminated NCT04474678
Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!") No drug interventions treatment Not Available completed NCT02347878
Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH) No drug interventions prevention 4 unknown_status NCT04188678
Resiliency in Older Adults Undergoing Bone Marrow Transplant No drug interventions other Not Available active_not_recruiting NCT00004878
Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia supportive_care 2 withdrawn NCT00897078
Study of Metabolic Syndrome in Young Patients Who Are Acute Lymphoblastic Leukemia Survivors and Their Healthy Siblings No drug interventions Not Available Not Available completed NCT00413478
5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia No drug interventions treatment 2 terminated NCT00002778
Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia treatment 2 terminated NCT00041288
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL treatment 2 terminated NCT06155188
Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia No drug interventions treatment Not Available recruiting NCT00002788
High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia treatment 1 completed NCT00739388
Azacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Who Are Unsuitable For Intensive Chemotherapy No drug interventions treatment 2 completed NCT01230788
Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia No drug interventions treatment Not Available terminated NCT02643888
Pre-existing Kinase Domain Mutations in Ph-positive Leukemias No drug interventions Not Available Not Available recruiting NCT00002688
Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia treatment 2 unknown_status NCT06001788
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia No drug interventions treatment 1 recruiting NCT01204788
Prophylactic White Cell Transfusions Versus Therapeutic White Cell Transfusions in Patients With Leukemia No drug interventions prevention 2 terminated NCT01298388
Study of Long-Term Outcomes of Patients With Acute Lymphoblastic Leukemia Who Were Enrolled as Children on Clinical Trials EORTC-58741, EORTC-58831, EORTC-58832, or EORTC-58881 Between 1971 and 1998 No drug interventions Not Available Not Available unknown_status NCT05826288
Oncology Care at Home for BMT and CAR-T No drug interventions supportive_care Not Available active_not_recruiting NCT03058588
Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes No drug interventions Not Available Not Available recruiting NCT05062707
Early Ageing During Therapy in AYA Cancer Patients No drug interventions Not Available Not Available recruiting NCT00038207
Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies treatment 2 completed NCT00004107
Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia treatment 1 / 2 completed NCT00072007
Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL treatment 2 completed NCT01290107
Biomarkers in Samples of Bone Marrow From Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT02608307
Medical Treatment Decision Making Using Adaptive Conjoint Analysis No drug interventions Not Available Not Available terminated NCT00003407
Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML supportive_care 2 withdrawn NCT00274807
Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia No drug interventions treatment 2 completed NCT00764907
Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia No drug interventions treatment 3 unknown_status NCT00012207
Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma treatment 1 completed NCT05203809
Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignancies No drug interventions Not Available Not Available unknown_status NCT00002609
Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission treatment 2 completed NCT00002809
Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00085709
S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML treatment 3 completed NCT01029509
Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes No drug interventions treatment 1 terminated NCT03702309
Liquid Biopsy Evaluation and Repository Development at Princess Margaret No drug interventions Not Available Not Available recruiting NCT00943709
Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia No drug interventions supportive_care 3 withdrawn NCT00087009
Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation treatment 1 terminated NCT00724009
Clofarabine Bone Marrow Cytoreduction No drug interventions treatment 2 completed NCT00540956
Natural Killer Cells in Older Patients With Acute Myeloid Leukemia No drug interventions treatment Not Available completed NCT00004056
Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia treatment 1 completed NCT01380756
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia No drug interventions treatment 1 completed NCT00002956
Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants No drug interventions treatment 1 withdrawn NCT01150656
Obatoclax Mesylate in Samples From Young Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00277056
Dysregulated Tyrosine Kinase Signaling in Leukemia No drug interventions Not Available Not Available terminated NCT00019656
Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer treatment 1 completed NCT00494585
CEP-701 for PH-negative Myelofibrosis No drug interventions treatment 2 completed NCT06357585
Providing Web-based Training to Parents Of Children With Leukemia No drug interventions supportive_care Not Available completed NCT05049785
Nutrition and Physical Activity Intervention in Preventing Excess Weight Gain in Pediatric Patients With Leukemia or Lymphoma Treated With Prednisone and/or Dexamethasone No drug interventions supportive_care Not Available active_not_recruiting NCT00064285
Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer treatment 1 completed NCT05745285
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care No drug interventions supportive_care Not Available not_yet_recruiting NCT00005585
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia treatment 3 completed NCT00317785
Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases No drug interventions treatment 2 completed NCT02786485
Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT No drug interventions treatment 1 withdrawn NCT00265915
Rituximab and GM-CSF in Treating Patients With Chronic Lymphocytic Leukemia No drug interventions treatment 2 terminated NCT00310115
Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy No drug interventions Not Available Not Available completed NCT00899015
Assessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070J No drug interventions Not Available Not Available completed NCT00245115
Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia No drug interventions treatment 1 terminated NCT03271515
Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL No drug interventions treatment 1 unknown_status NCT02469415
Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS) No drug interventions treatment 2 terminated NCT00132015
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis No drug interventions treatment 2 completed NCT00945815
S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia No drug interventions treatment 2 completed NCT00891137
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy No drug interventions supportive_care 1 completed NCT00003437
Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia treatment 3 unknown_status NCT00648037
Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT No drug interventions treatment Not Available completed NCT00952237
Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF No drug interventions treatment 1 completed NCT01875237
Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene No drug interventions treatment 1 / 2 terminated NCT02067637
Delayed Effects of Treatment in Cancer Survivors (DETECS) No drug interventions Not Available Not Available withdrawn NCT00265837
Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer No drug interventions treatment 3 completed NCT01920737
A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia No drug interventions treatment 2 active_not_recruiting NCT00001637
Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults No drug interventions treatment 2 completed NCT00422032
2 Arm Study of Clofarabine IV in MDS Patients No drug interventions treatment 2 completed NCT00295932
Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma No drug interventions treatment 1 / 2 completed NCT00004132
Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer supportive_care 2 completed NCT00321932
Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant No drug interventions treatment 2 completed NCT01116232
Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation No drug interventions supportive_care 2 terminated NCT00002532
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia treatment 2 unknown_status NCT01138332
Biomarkers in Young Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT02598752
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation No drug interventions Not Available Not Available completed NCT00253552
G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders No drug interventions treatment Not Available terminated NCT01362452
Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells No drug interventions treatment 1 completed NCT01602952
Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI No drug interventions treatment 1 / 2 completed NCT00556452
Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen No drug interventions treatment 1 / 2 completed NCT03086252
Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study No drug interventions supportive_care Not Available withdrawn NCT00899652
DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT00002700
Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia treatment 3 completed NCT01755000
Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings No drug interventions supportive_care Not Available completed NCT00509600
Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia No drug interventions treatment 2 terminated NCT00042900
Pyroxamide in Treating Patients With Advanced Cancer treatment 1 completed NCT00505700
VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia No drug interventions treatment 1 completed NCT01067300
A Study Comparing Single Versus Double Umbilical Cord Blood Transplantation in the Young With Acute Leukemia Remission No drug interventions treatment 3 unknown_status NCT00660400
Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Allogeneic Hematopoietic Cell Transplant No drug interventions treatment Not Available completed NCT00943800
Combined Haploidentical-Cord Blood Transplantation for Adults and Children No drug interventions treatment Not Available completed NCT00387959
Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma No drug interventions treatment 2 completed NCT00143559
Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies No drug interventions treatment 2 completed NCT00003659
Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia treatment 2 completed NCT00012259
Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia treatment 2 completed NCT00631059
Assessment and Determination of Chemotherapy Resistance in Newly-Diagnosed or First Relapse Leukemia Patients No drug interventions treatment Not Available terminated NCT00003959
Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome treatment 1 completed NCT00996359
Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation No drug interventions treatment 1 terminated NCT00267059
Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL) No drug interventions treatment 2 completed NCT00072475
Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes treatment 2 completed NCT01421875
Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00086775
Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia treatment 2 completed NCT03410875
A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia No drug interventions treatment 2 active_not_recruiting NCT04163575
Immunotherapy With CD22 CAR T-cells for B-Cell Lymphoma, ALL and CLL No drug interventions treatment 1 / 2 unknown_status NCT00112775
BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate treatment 2 unknown_status NCT00006475
STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis treatment 2 completed NCT00003675
Topotecan in Treating Patients With Myelodysplastic Syndrome treatment 2 completed NCT03564470
Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL No drug interventions treatment 2 / 3 unknown_status NCT00083070
Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia treatment 1 completed NCT00003270
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00822770
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin No drug interventions treatment 1 / 2 completed NCT01392170
Pegasys in Patients With Chronic Myeloid Leukemia (CML) No drug interventions treatment 2 terminated NCT00021242
Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia treatment 2 completed NCT00268242
Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia No drug interventions treatment 2 terminated NCT00186342
Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies No drug interventions treatment Not Available completed NCT02096042
Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML) No drug interventions treatment 1 / 2 terminated NCT00920842
Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant No drug interventions Not Available Not Available completed NCT03910842
Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy No drug interventions treatment 0 unknown_status NCT00424242
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases No drug interventions treatment 0 completed NCT00017342
Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia treatment 2 completed NCT00940342
Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic Lymphocytic Leukemia No drug interventions treatment 2 completed NCT00569842
Investigation of the Cylex® ImmuKnow® Assay No drug interventions Not Available Not Available completed NCT03759899
hAECs Are Preliminarily Applied in Allogeneic Hematopoietic Stem Cell Transplantation No drug interventions Not Available Not Available unknown_status NCT00899899
Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission No drug interventions Not Available Not Available completed NCT00066599
Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy supportive_care 2 completed NCT00086099
Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia treatment 1 / 2 completed NCT01057199
Studying Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00028899
Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes treatment 1 completed NCT02012699
Integrated Cancer Repository for Cancer Research No drug interventions Not Available Not Available recruiting NCT00156299
Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate No drug interventions treatment 1 terminated NCT00827099
Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer No drug interventions treatment 2 terminated NCT00058799
Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor Vaccine No drug interventions treatment 1 completed NCT01138306
Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00005606
Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation No drug interventions treatment 2 completed NCT03244306
A Phase 1 Study of CD22-CAR TCell Immunotherapy for CD22+ Leukemia and Lymphoma No drug interventions treatment 1 active_not_recruiting NCT00453206
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases No drug interventions treatment Not Available completed NCT00676806
A Phase II Study of Umbilical Cord Blood Transplantation No drug interventions treatment 2 terminated NCT00003406
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer treatment 1 / 2 completed NCT06429449
Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia No drug interventions treatment 1 recruiting NCT02129049
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children No drug interventions supportive_care Not Available completed NCT00085449
Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer treatment 1 / 2 withdrawn NCT04547049
A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies No drug interventions treatment 3 recruiting NCT01746849
Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation No drug interventions treatment 2 active_not_recruiting NCT00255749
Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer No drug interventions supportive_care 2 completed NCT05536349
Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT) No drug interventions treatment 2 recruiting NCT00990249
Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation No drug interventions treatment 2 completed NCT00736749
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies No drug interventions Not Available Not Available recruiting NCT00363649
Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI No drug interventions treatment 2 completed NCT00472849
Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias No drug interventions treatment 1 / 2 completed NCT01135849
B-Receptor Signaling in Cardiomyopathy No drug interventions Not Available Not Available completed NCT00719849
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease No drug interventions treatment 2 terminated NCT04965649
Is There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance Mutations in Phi+ Hematological Malignancies. No drug interventions Not Available Not Available recruiting NCT00003336
Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions treatment 2 completed NCT00624936
Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes No drug interventions treatment 1 completed NCT06430736
PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab) No drug interventions treatment 2 recruiting NCT00098436
Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias treatment 1 completed NCT00897936
DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00054236
Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia treatment 1 completed NCT02948413
Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials No drug interventions Not Available Not Available completed NCT00253513
Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome No drug interventions treatment 1 / 2 completed NCT00898118
Studying Blood Samples in Young Patients With Cytopenia After a Donor Stem Cell Transplant No drug interventions Not Available Not Available unknown_status NCT00005618
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia treatment 2 completed NCT00534118
Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant No drug interventions treatment Not Available completed NCT00350818
Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT) No drug interventions treatment 1 completed NCT00096018
Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia treatment 1 / 2 completed NCT00281918
Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia No drug interventions treatment 3 completed NCT05645718
Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia No drug interventions treatment 2 recruiting NCT00002818
High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies treatment 1 completed NCT01138319
Biomarkers in Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00943319
Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies No drug interventions treatment 1 / 2 completed NCT01919619
Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies No drug interventions treatment 1 completed NCT00372619
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia No drug interventions treatment 1 / 2 completed NCT00002719
Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia treatment 3 completed NCT01828619
Study of New RIC Regimen of BuFlu in Older and/or Intolerable Patients No drug interventions Not Available Not Available unknown_status NCT00016419
S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome treatment 2 completed NCT00005619
Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia No drug interventions Not Available Not Available completed NCT00498719
Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer No drug interventions Not Available Not Available active_not_recruiting NCT00770419
Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers No drug interventions Not Available Not Available withdrawn NCT01092741
Late Chronic Phase Chronic Myelogenous Leukemia No drug interventions treatment 2 completed NCT00295841
Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia No drug interventions treatment 1 completed NCT00290641
Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer No drug interventions treatment Not Available completed NCT00739141
Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies. No drug interventions treatment 2 completed NCT01503541
S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin No drug interventions Not Available Not Available completed NCT01117441
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia No drug interventions treatment 3 completed NCT00004217
S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia treatment 2 completed NCT03173417
Safety and Efficacy Evaluation of IM19 CAR-T Cells (IM19CAR-T) No drug interventions treatment 1 / 2 completed NCT00949117
Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer No drug interventions supportive_care 2 terminated NCT01653717
CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL) No drug interventions treatment 1 completed NCT01019317
Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) No drug interventions treatment 2 completed NCT01235117
Azacitidine in Treating Patients With Chronic Myelomonocytic Leukemia No drug interventions treatment 2 completed NCT00002517
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome treatment 3 completed NCT01020734
Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in Remission No drug interventions treatment 2 completed NCT00043134
Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome treatment 3 unknown_status NCT00049634
Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder treatment 1 / 2 completed NCT00091234
Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia treatment 2 / 3 unknown_status NCT00541034
Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia No drug interventions treatment 2 completed NCT00011934
Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia treatment 2 completed NCT05179824
Tempus Priority Study: A Pan-tumor Observational Study No drug interventions Not Available Not Available recruiting NCT04372524
Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study No drug interventions Not Available Not Available recruiting NCT00940524
Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia No drug interventions treatment 1 completed NCT04977024
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer No drug interventions treatment 2 recruiting NCT00900224
Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available active_not_recruiting NCT00823524
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer No drug interventions treatment 1 / 2 completed NCT00349024
Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer No drug interventions supportive_care Not Available unknown_status NCT00813124
Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML) No drug interventions treatment 2 completed NCT00416624
Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy No drug interventions supportive_care 2 completed NCT01229124
RNA Biomarkers in Tissue Samples From Infants With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00027924
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome treatment 2 completed NCT00732316
Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome No drug interventions treatment 2 completed NCT00582816
Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors No drug interventions treatment 1 / 2 terminated NCT00651716
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant No drug interventions Not Available Not Available terminated NCT00003116
High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00737516
Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation No drug interventions Not Available 2 completed NCT03654716
Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer No drug interventions treatment 1 completed NCT00612716
Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia No drug interventions treatment 2 completed NCT00482716
Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer No drug interventions supportive_care 3 unknown_status NCT03342196
Thiotepa Plus Fludarabine+ Melphalan as the Preparative Regime for Alternative Donor Transplantation No drug interventions treatment 2 completed NCT00118196
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia treatment 2 terminated NCT01593696
Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma No drug interventions treatment 1 completed NCT00096096
Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation supportive_care 2 completed NCT00053196
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer treatment 2 completed NCT02584296
Physical Activity as Self-Management Approach to Improve Health Outcomes in AML No drug interventions Not Available Not Available completed NCT00547196
AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders No drug interventions treatment Not Available completed NCT00886496
Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia No drug interventions supportive_care 1 withdrawn NCT06501196
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome No drug interventions treatment 1 recruiting NCT00618696
Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia No drug interventions treatment 1 terminated NCT00062296
Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia treatment 2 completed NCT00918658
Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer No drug interventions Not Available Not Available terminated NCT06347458
BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children No drug interventions treatment 1 not_yet_recruiting NCT01150058
Drug Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00129558
A Study to Evaluate PT-523 in Patients With Refractory Leukemia treatment 1 / 2 withdrawn NCT00671658
Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia No drug interventions treatment 2 completed NCT00003658
Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers treatment 2 completed NCT02158858
A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis No drug interventions treatment 1 / 2 active_not_recruiting NCT03600558
Efficacy of FLAG Regimen for the Treatment of Patients With AML No drug interventions Not Available Not Available unknown_status NCT01005758
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia No drug interventions treatment 2 unknown_status NCT00004258
EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer treatment 1 completed NCT00477035
Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies No drug interventions prevention 1 completed NCT00003735
Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia treatment 2 completed NCT00549835
Acupuncture for Mucositis Pain in Cancer Care No drug interventions supportive_care Not Available withdrawn NCT00890435
Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial No drug interventions Not Available Not Available completed NCT00003335
Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer treatment 2 completed NCT00003635
506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents treatment 2 completed NCT01227135
Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia No drug interventions treatment 2 unknown_status NCT01532635
A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives No drug interventions treatment 2 terminated NCT03233763
Laboratory Studies Into the Pathology of Leukaemia No drug interventions Not Available Not Available unknown_status NCT01324063
A Randomized Phase III Study of Intensive Consolidation With High Dose Cytosine Arabinoside in Acute Myelogenous Leukemia (AML-8B) No drug interventions treatment 3 completed NCT02007863
Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia No drug interventions treatment Not Available completed NCT00529763
Dasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Advanced Phase) Subjects No drug interventions treatment 2 completed NCT00005863
Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia treatment 3 completed NCT00719563
American Ginseng in Treating Patients With Fatigue Caused by Cancer No drug interventions supportive_care 3 completed NCT05763563
Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy No drug interventions supportive_care Not Available recruiting NCT04265963
CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid Leukemia No drug interventions treatment 1 / 2 recruiting NCT00884286
Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma No drug interventions treatment 2 completed NCT03624686
Production of Clinical-grade Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory B-cell Malignancies No drug interventions Not Available Not Available unknown_status NCT00364286
Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825) No drug interventions treatment 2 completed NCT00001686
Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases No drug interventions Not Available Not Available completed NCT00437086
Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders No drug interventions treatment 0 completed NCT00004086
Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer treatment 1 unknown_status NCT00754286
A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer No drug interventions supportive_care Not Available completed NCT00003239
Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia treatment 2 completed NCT01154439
Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia No drug interventions treatment 1 completed NCT01050439
Unrelated Donor Transplant for Malignant and Non-Malignant Disorders No drug interventions treatment 2 terminated NCT00006239
Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer treatment 1 completed NCT00578539
T-Reg Cell Kinetics, Stem Cell Transplant, REGALE No drug interventions treatment Not Available terminated NCT00800839
Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide No drug interventions treatment 2 completed NCT00506922
Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT No drug interventions treatment 1 / 2 completed NCT00006122
Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia treatment 2 completed NCT00045422
Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia treatment 2 completed NCT00005622
Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders treatment 2 completed NCT00042822
FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma treatment 2 completed NCT00860522
JVRS-100 for the Treatment of Patients With Relapsed or Refractory Leukemia No drug interventions treatment 1 completed NCT04272125
Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia No drug interventions treatment 1 / 2 recruiting NCT00086125
Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED) treatment 2 completed NCT01240525
Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers No drug interventions treatment 2 unknown_status NCT00002925
Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia treatment 1 / 2 completed NCT04610125
Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children No drug interventions treatment Not Available recruiting NCT03121625
CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies No drug interventions treatment 1 unknown_status NCT00015925
MS-275 in Treating Patients With Hematologic Cancer treatment 1 completed NCT00023530
Blood and Marrow Transplant Clinical Research Network prevention Not Available completed NCT00248430
Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer No drug interventions treatment 1 / 2 completed NCT00003230
Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia treatment 1 / 2 completed NCT00534430
Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer No drug interventions treatment 2 active_not_recruiting NCT00777530
Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy Subjects No drug interventions Not Available 1 completed NCT02089230
MEK Inhibitor 162 Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Poor Prognosis, Not Suitable for or Unwilling to Receive Standard Therapy No drug interventions treatment 1 / 2 terminated NCT02360930
Vincristine PK and PD in the AYA Population Compared to Younger Children No drug interventions Not Available Not Available unknown_status NCT00726830
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer No drug interventions supportive_care Not Available terminated NCT03016130
Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BMT-LDND-101) No drug interventions supportive_care 3 terminated NCT00867230
FTS Study in Patients With Advanced Hematologic Malignancies No drug interventions treatment 1 completed NCT00028730
Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer treatment 2 completed NCT03556748
WB-EMS and Nutrition in Patients With Hematological Malignancies No drug interventions supportive_care Not Available unknown_status NCT00947648
Outpatient Neutropenic Diet Study No drug interventions Not Available 2 terminated NCT00066248
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment supportive_care 2 completed NCT03066648
Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS No drug interventions treatment 1 completed NCT02251548
A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia No drug interventions treatment 2 active_not_recruiting NCT00506948
Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD) No drug interventions treatment 2 terminated NCT00074048
BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell Leukemia No drug interventions treatment 2 completed NCT00053248
Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia treatment 1 / 2 completed NCT01596257
Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation No drug interventions treatment 2 completed NCT00410657
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant No drug interventions supportive_care 2 completed NCT00462657
Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease No drug interventions diagnostic Not Available unknown_status NCT02464657
Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) No drug interventions treatment 1 / 2 completed NCT05673057
Study of MP0533 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome No drug interventions treatment 1 / 2 recruiting NCT01407757
Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531 No drug interventions Not Available Not Available completed NCT00114257
Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders treatment 1 completed NCT00004857
Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia treatment 2 completed NCT00003757
Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy treatment 2 completed NCT00002757
TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma treatment 3 completed NCT00427557
Cellular Therapy With Cord Blood Cells No drug interventions treatment 2 completed NCT02196857
Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation No drug interventions treatment 2 completed NCT00053157
Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia supportive_care Not Available completed NCT01289457
Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome No drug interventions treatment 1 / 2 completed NCT01064557
"AIDA" Protocol (LAP 0493) No drug interventions treatment Not Available unknown_status NCT03953326
HeartPhone Cancer Survivors Trial 2019 No drug interventions prevention 1 / 2 terminated NCT00066326
Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia treatment 1 completed NCT03373526
Effects of Aerobic Training and Inspiratory Muscle Training in Patients During Hematopoietic Stem Cell Transplantation No drug interventions treatment Not Available unknown_status NCT01682226
Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies No drug interventions treatment 2 completed NCT00951626
A Standardized Nursing Intervention Protocol for HCT Patients No drug interventions health_services_research Not Available completed NCT01212926
Early Detection of Anthracycline Cardiotoxicity by Echocardiographic Analysis of Myocardial Deformation in 2D Strain No drug interventions diagnostic Not Available completed NCT00022126
Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia treatment 2 completed NCT00960726
NOV-002 in Myelodysplastic Syndrome (MDS) No drug interventions treatment 2 withdrawn NCT00627666
Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer No drug interventions treatment 2 completed NCT00566566
Adipokines as Predictors of the Metabolic Syndrome in ALL Survivors No drug interventions Not Available Not Available unknown_status NCT00896766
Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT04556266
A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies No drug interventions treatment 1 withdrawn NCT00800566
Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL) No drug interventions treatment 1 withdrawn NCT00899366
DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT00093366
Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes treatment 1 / 2 completed NCT00006265
Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia treatment 2 completed NCT04136665
Physical Activity Adapted at Home Supervised by Videoconferencing in Post-cancer for Children / AYA Treated for Leukemia (ONCOPED SAPATIC) No drug interventions prevention Not Available terminated NCT00672165
Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies No drug interventions treatment 1 completed NCT02291965
Blood Samples to Identify Biomarkers of Busulfan No drug interventions Not Available Not Available active_not_recruiting NCT00020865
Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia supportive_care 3 unknown_status NCT01004965
Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720 No drug interventions Not Available Not Available completed NCT01251965
Phase l/II Study of Ruxolitinib for Acute Leukemia No drug interventions treatment 1 / 2 terminated NCT00002865
High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia treatment 2 completed NCT00357565
Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia No drug interventions treatment 2 active_not_recruiting NCT00559065
A Case-Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in China No drug interventions Not Available Not Available completed NCT00002665
SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia treatment 2 completed NCT00452374
Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL No drug interventions treatment 1 / 2 completed NCT00003174
Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia treatment 1 completed NCT01184274
A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and Leukemia No drug interventions treatment 1 completed NCT01338974
S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00081874
RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma treatment 1 / 2 completed NCT00003874
Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia No drug interventions treatment 1 / 2 completed NCT00513474
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant No drug interventions supportive_care 1 completed NCT00055874
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia treatment 3 completed NCT00070174
Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy treatment 2 completed NCT01416974
Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and Rituximab No drug interventions treatment 1 completed NCT00274820
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder No drug interventions treatment 2 completed NCT01323920
Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors No drug interventions treatment 2 completed NCT00504920
Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients No drug interventions Not Available Not Available completed NCT01929720
Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors No drug interventions supportive_care Not Available completed NCT00469820
Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant No drug interventions treatment 1 terminated NCT00006220
Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy treatment 1 / 2 terminated NCT00881920
Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL No drug interventions treatment 1 recruiting NCT00392782
Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease No drug interventions treatment 2 terminated NCT00410982
Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies No drug interventions treatment 1 completed NCT00897182
Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT02795182
Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies No drug interventions treatment 1 completed NCT00305682
Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant No drug interventions treatment 2 completed NCT00230282
Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia No drug interventions treatment 2 completed NCT00070382
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer supportive_care 3 completed NCT00109031
Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE) supportive_care 3 completed NCT01228331
Clofarabine or High-Dose Cytarabine and Pegaspargase in Children With ALL No drug interventions treatment 2 / 3 active_not_recruiting NCT00003931
Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00801931
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders No drug interventions treatment 1 / 2 terminated NCT05362331
Companion for CAR-T Web App During Chimeric Antigen Receptor T-cell Therapy No drug interventions health_services_research Not Available withdrawn NCT00978731
Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemic Study No drug interventions treatment 1 completed NCT00003331
Combination Chemotherapy in Treating Patients With Advanced Cancer treatment 1 completed NCT00642031
Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies No drug interventions treatment 1 completed NCT00053131
Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia treatment 2 completed NCT02601131
Post-transfusion Platelet Count No drug interventions Not Available Not Available completed NCT03399331
Honey or Olive Oil for Treating Oral Mucositis in Children and Adults With Leukemia Receiving Intensive Chemotherapy No drug interventions treatment 1 completed NCT00466531
Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 No drug interventions treatment 1 / 2 active_not_recruiting NCT01139931
Biomarker Changes in Samples From Young Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT01009931
Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies No drug interventions treatment 2 terminated NCT01245231
Prognostic Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00840931
Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS) No drug interventions treatment 1 completed NCT00918931
Obatoclax for Systemic Mastocytosis No drug interventions treatment 2 terminated NCT00899873
Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997 No drug interventions Not Available Not Available completed NCT01383473
Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients No drug interventions Not Available Not Available completed NCT00003673
CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse treatment 2 completed NCT00003073
Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors treatment 1 unknown_status NCT00535873
Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older No drug interventions treatment 2 completed NCT01617473
Randomized Trial of Mobilized Blood/Marrow Versus Blood Transplant No drug interventions Not Available Not Available withdrawn NCT02420873
An Open-label Phase II Study of Lorvotuzumab Mertansine No drug interventions treatment 2 completed NCT01515527
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) No drug interventions treatment 2 recruiting NCT00003827
Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome treatment 2 unknown_status NCT00769327
Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia No drug interventions treatment 2 completed NCT00054327
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer treatment 2 completed NCT01596127
Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System No drug interventions treatment 1 / 2 terminated NCT05646576
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy No drug interventions supportive_care Not Available recruiting NCT01139476
Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study No drug interventions Not Available Not Available completed NCT02530476
Phase I/II, Study of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) + Sorafenib in Acute Myeloid Leukemia No drug interventions treatment 1 / 2 completed NCT04706676
Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer No drug interventions prevention Not Available recruiting NCT00068276
Cholecalciferol in Treating Patients With Myelodysplastic Syndrome No drug interventions treatment 2 completed NCT00085176
Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT01295476
Biomarker Study in Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT01094860
Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies No drug interventions treatment 1 completed NCT00301860
Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer No drug interventions treatment Not Available terminated NCT01508260
Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload No drug interventions treatment Not Available withdrawn NCT00457860
Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease No drug interventions treatment 1 unknown_status NCT00002494
Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia treatment 2 completed NCT00993694
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone No drug interventions Not Available Not Available completed NCT01011894
Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age No drug interventions treatment 2 completed NCT00066794
S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia treatment 2 completed NCT00003294
Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer treatment 1 completed NCT06408194
Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies No drug interventions treatment 1 recruiting NCT05479994
Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma No drug interventions treatment 2 recruiting NCT00083694
Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia treatment 2 completed NCT01643291
Ultrasound Use for Difficult Lumbar Punctures in Pediatric Oncology Patients No drug interventions treatment Not Available terminated NCT00133991
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia No drug interventions treatment 2 completed NCT02735291
Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Acute Non T Lymphocyte Leukemia No drug interventions treatment Not Available active_not_recruiting NCT00003991
Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia treatment 3 completed NCT02546791
Frequency and Severity of Pleural Effusion Associated With the Use of Dasatinib in Patients With Chronic Myeloid Leukemia. A Descriptive, Mexican Multicenter Study No drug interventions Not Available Not Available completed NCT05063591
Removing Transfusion Dependence as a Barrier to Hospice Enrollment No drug interventions supportive_care Not Available active_not_recruiting NCT01421862
Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment No drug interventions Not Available Not Available unknown_status NCT00005962
Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia treatment 2 completed NCT00006362
PS-341 in Treating Patients With Advanced Cancer treatment 1 completed NCT00624962
Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors No drug interventions supportive_care Not Available withdrawn NCT01553162
Studying Dexamethasone and Prednisone Sensitivity in Samples From Younger Patients With High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT00149162
Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2 No drug interventions treatment 3 unknown_status NCT00003662
Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases treatment 2 completed NCT00900380
Studying Tissue Samples to Learn More About Drug Resistance in Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00024180
FR901228 in Treating Patients With Hematologic Cancer treatment 1 completed NCT00005580
Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma treatment 1 completed NCT00454480
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes No drug interventions treatment 2 / 3 completed NCT00376480
Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant No drug interventions treatment 1 completed NCT00002980
Decitabine in Treating Patients With Melanoma or Other Advanced Cancer treatment 1 completed NCT00321880
Healing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic Leukemia No drug interventions supportive_care Not Available completed NCT02932280
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment No drug interventions treatment 1 / 2 active_not_recruiting NCT00003829
Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia treatment 2 completed NCT00026429
Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma treatment 2 unknown_status NCT00764829
Blood Samples to Evaluate Biomarkers of Donor Chimerism No drug interventions Not Available Not Available completed NCT00003729
Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia treatment 2 terminated NCT00268229
Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia No drug interventions treatment 1 completed NCT03948529
RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation No drug interventions treatment 2 unknown_status NCT01135329
Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers No drug interventions treatment 2 terminated NCT00493129
Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM) No drug interventions treatment 2 completed NCT00476229
Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies No drug interventions treatment Not Available completed NCT02859389
Neurocognitive and Psychosocial Outcomes in Survivors of Childhood Leukemia With Down Syndrome No drug interventions Not Available Not Available completed NCT00857389
Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies No drug interventions treatment 2 completed NCT01511289
Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients No drug interventions treatment 3 completed NCT01342289
Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide No drug interventions treatment 1 completed NCT00462189
Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease No drug interventions treatment 1 unknown_status NCT06262789
RAT-HEMATO : Return to Work After Malignant Hemopathy No drug interventions supportive_care Not Available not_yet_recruiting NCT04037189
Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia No drug interventions Not Available Not Available unknown_status NCT00871689
Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML No drug interventions treatment 2 terminated NCT00180089
Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation No drug interventions prevention 3 completed NCT00053989
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders treatment 2 completed NCT00499889
Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients No drug interventions treatment 2 terminated NCT00185692
Allogeneic Transplantation From Related Haploidentical Donors No drug interventions treatment 2 completed NCT00526292
Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant No drug interventions treatment 2 completed NCT00002592
Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia treatment 2 completed NCT00898092
Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available unknown_status NCT00006092
Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia treatment 2 terminated NCT00469144
IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome No drug interventions treatment 3 completed NCT01931644
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions No drug interventions Not Available Not Available completed NCT01410344
Allogeneic Transplant in HIV Patients (BMT CTN 0903) No drug interventions treatment 2 completed NCT01471444
Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) No drug interventions treatment 3 completed NCT00362544
PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute Leukaemia No drug interventions prevention 4 completed NCT00621244
A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies No drug interventions treatment 1 / 2 completed NCT00450944
Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia No drug interventions treatment 1 completed NCT00002844
Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia treatment 2 completed NCT00038844
Safety and Efficacy of Campath in Nonmyeloablative Transplantation treatment Not Available completed NCT00062140
Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 1 completed NCT01077440
Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant No drug interventions Not Available Not Available terminated NCT03793140
A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations No drug interventions treatment 2 active_not_recruiting NCT00003340
Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia treatment 2 completed NCT00054340
Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder supportive_care 1 / 2 completed NCT00755040
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder No drug interventions prevention 3 completed NCT00500240
Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL) No drug interventions treatment 3 terminated NCT00119340
Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous Leukemia treatment 1 / 2 completed NCT00186940
Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients No drug interventions Not Available Not Available completed NCT00740467
Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders No drug interventions treatment 2 unknown_status NCT00782067
Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia No drug interventions treatment 2 completed NCT01471067
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies No drug interventions treatment 1 completed NCT06409767
Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation. No drug interventions treatment Not Available not_yet_recruiting NCT00005967
Tipifarnib in Treating Patients With Advanced Hematologic Cancer treatment 1 completed NCT00112567
Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer No drug interventions treatment 1 / 2 completed NCT02323867
Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies No drug interventions treatment 2 recruiting NCT05123001
Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events No drug interventions supportive_care Not Available recruiting NCT04336501
Efficacy and Safety Evaluation of IM19 CAR-T Cell Therapy for MRD+ After Transplantation No drug interventions treatment Not Available unknown_status NCT00618501
Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia No drug interventions treatment 2 completed NCT00972101
Infusion of Expanded Cord Blood T Cells No drug interventions treatment 1 withdrawn NCT06131801
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution No drug interventions Not Available Not Available recruiting NCT05480501
Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia No drug interventions treatment 0 recruiting NCT00813501
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases No drug interventions Not Available Not Available terminated NCT00352001
Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes No drug interventions treatment 1 / 2 completed NCT02378701
Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease No drug interventions Not Available Not Available completed NCT00005801
Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia treatment 2 completed NCT00076401
A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) treatment 2 terminated NCT00534001
Bupropion in Helping Adults Stop Smoking No drug interventions other 2 completed NCT00448201
Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease No drug interventions treatment 2 completed NCT00075101
Sleep, Fatigue, and Dexamethosone in Children With Leukemia treatment 3 completed NCT03319901
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL No drug interventions treatment 1 / 2 recruiting NCT00053001
Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome supportive_care 2 completed NCT00002701
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia treatment 3 unknown_status NCT03226704
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing No drug interventions Not Available Not Available enrolling_by_invitation NCT01025804
Pharmacokinetics of Asparaginase and Antibody Formation in Interfant-06 No drug interventions Not Available Not Available completed NCT00004904
Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 1 completed NCT01411904
A Novel Magnetic Needle Using Iron Oxide Nanoparticles for the Detection of Leukemia No drug interventions diagnostic Not Available withdrawn NCT03564704
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL No drug interventions treatment 2 / 3 unknown_status NCT00290004
Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma No drug interventions treatment 1 / 2 completed NCT01287104
A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediatric Patients With Solid Tumors and Leukemias No drug interventions treatment 1 completed NCT00963872
Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer No drug interventions treatment 1 / 2 terminated NCT00003572
Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers treatment 2 completed NCT00052572
Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders treatment 2 completed NCT01893372
Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS) No drug interventions treatment 2 completed NCT03934372
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03883672
Socio-psychological Factors Involved in the Hematopoietic Stem Cell Transplantation Process in People With Hemopathies No drug interventions other Not Available completed NCT02159872
Omacetaxine in Patients With Intermediate-1 and Higher Risk Myelodysplastic Syndrome (MDS) Post Hypomethylating Agent (HMA) Failure No drug interventions treatment 2 completed NCT00002868
Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia treatment 3 completed NCT00179868
C-Reactive Protein as a Predictor of Stem Cell Transplant Complications No drug interventions Not Available Not Available completed NCT00337168
S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia No drug interventions treatment 2 completed NCT01533168
Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT00002768
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission treatment 2 completed NCT01570868
Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP) No drug interventions treatment 2 terminated NCT00454168
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission No drug interventions treatment 3 unknown_status NCT00499668
Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer No drug interventions supportive_care Not Available withdrawn NCT01149668
A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer No drug interventions treatment 1 completed NCT06053268
Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors No drug interventions treatment Not Available enrolling_by_invitation NCT00047268
Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome diagnostic 3 unknown_status NCT01891968
Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation No drug interventions treatment 2 completed NCT01117168
Enrollment on the Childhood Cancer Research Network (CCRN) of the Children s Oncology Group No drug interventions Not Available Not Available terminated NCT02419469
Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma No drug interventions treatment 2 terminated NCT01044069
Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 No drug interventions treatment 1 active_not_recruiting NCT00812669
CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7 No drug interventions treatment 2 completed NCT00790569
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking No drug interventions prevention Not Available completed NCT01145469
Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based Therapy No drug interventions Not Available Not Available completed NCT00002869
Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia treatment 3 unknown_status NCT00056069
Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia No drug interventions treatment Not Available completed NCT00511069
Velcade (Bortezomib - PS341) in the Treatment of Patients Over 18 Years With Ph+ Leukemia No drug interventions treatment 2 completed NCT01520246
Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia No drug interventions Not Available Not Available completed NCT00005946
Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation treatment 1 completed NCT00337246
Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia No drug interventions treatment 2 completed NCT00126646
BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma No drug interventions treatment 1 completed NCT00002746
Interleukin-2 in Treating Patients With Myelodysplastic Syndrome treatment 1 completed NCT05655546
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals No drug interventions other Not Available active_not_recruiting NCT00525746
Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS) No drug interventions Not Available Not Available active_not_recruiting NCT00113646
Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies No drug interventions treatment 2 terminated NCT00003746
Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia treatment 3 completed NCT00274846
Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia No drug interventions treatment 2 completed NCT00602446
Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant No drug interventions supportive_care 2 terminated NCT00231712
Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant No drug interventions Not Available Not Available unknown_status NCT00612612
Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia No drug interventions treatment 1 terminated NCT00002812
Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia treatment 3 completed NCT01101412
Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies No drug interventions supportive_care 1 / 2 withdrawn NCT06512012
Technology-Assisted Yoga and Exercise on Neuropathy and Pain in Children With Leukemia No drug interventions supportive_care Not Available completed NCT06229912
A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes No drug interventions treatment 2 recruiting NCT00036712
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation No drug interventions supportive_care 2 unknown_status NCT01932710
A Feasibility Study of Prophylactic White Blood Cell Transfusions No drug interventions prevention 2 completed NCT04271410
CD19+Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma No drug interventions treatment 1 / 2 recruiting NCT02385110
Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis No drug interventions treatment 2 completed NCT00003910
Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia treatment 2 terminated NCT00569010
Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) No drug interventions treatment 1 / 2 completed NCT01891981
Study of Moxetumomab Pasudotox in Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL) No drug interventions treatment 1 terminated NCT00023881
Bortezomib in Treating Patients With Chronic Myelogenous Leukemia treatment 2 terminated NCT00580281
Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors No drug interventions diagnostic Not Available completed NCT00740181
Decitabine, Cytarabine, GCSF for Refractory AML/MDS No drug interventions treatment 2 terminated NCT00002681
Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma treatment 1 / 2 completed NCT00005881
Quality of Life in Children Treated for Cancer No drug interventions Not Available Not Available completed NCT00899795
Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers No drug interventions Not Available Not Available completed NCT01057095
Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT01298414
Biomarkers in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00597714
Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant No drug interventions treatment 2 completed NCT01442714
Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDS No drug interventions treatment 2 terminated NCT01005914
Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia No drug interventions treatment 2 terminated NCT00423514
Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease No drug interventions treatment 1 / 2 completed NCT00053014
S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia treatment 2 terminated NCT00281814
Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant No drug interventions Not Available Not Available completed NCT01357655
Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923) No drug interventions treatment 2 terminated NCT01657955
Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia No drug interventions treatment 3 unknown_status NCT01232855
Biomarkers in Tissue Samples From Patients With Acute Promyelocytic Leukemia No drug interventions Not Available Not Available completed NCT00923650
Informed Consent in Pediatric Cancer Trials No drug interventions Not Available Not Available completed NCT00002750
Melphalan in Patients With Neoplastic Meningitis treatment 1 completed NCT02799550
Allogeneic CART-19 for Elderly Relapsed/Refractory CD19+ ALL No drug interventions treatment 1 unknown_status NCT00085150
LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma No drug interventions treatment 1 completed NCT01385150
Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00006350
Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00800150
Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment No drug interventions treatment 1 terminated NCT00528450
Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia No drug interventions treatment 2 terminated NCT00458523
Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete Remission No drug interventions treatment 2 completed NCT04101123
Children and Adolescents With Leukemia, Brain Tumors, and Sarcomas No drug interventions Not Available Not Available completed NCT02593123
Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis No drug interventions treatment 2 completed NCT01490723
Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT) No drug interventions treatment 2 completed NCT00185523
Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML) No drug interventions Not Available Not Available terminated NCT00006223
flt3L in Treating Patients With Acute Myeloid Leukemia No drug interventions treatment 3 completed NCT00005823
Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome treatment 3 completed NCT00104923
Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer treatment 1 completed NCT05871008
Integrated Actionable Aging Assessment for Cancer Patients Pilot No drug interventions health_services_research Not Available recruiting NCT00002908
Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia treatment 2 completed NCT01501708
Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection No drug interventions treatment 2 unknown_status NCT00006008
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia treatment 2 completed NCT00017108
Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia treatment 3 unknown_status NCT00003808
Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia treatment 2 completed NCT00889408
DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma No drug interventions treatment 1 completed NCT00030108
Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy treatment 1 completed NCT02450708
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes No drug interventions other Not Available active_not_recruiting NCT00920738
Metabolic Syndrome in Childhood Cancer Survivors No drug interventions Not Available Not Available completed NCT00019838
UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia treatment 1 completed NCT00398138
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma No drug interventions treatment 1 completed NCT00360438
Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS No drug interventions treatment 1 / 2 completed NCT00002838
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia treatment 1 / 2 completed NCT00002638
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia treatment 2 completed NCT01438138
Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia No drug interventions Not Available Not Available completed NCT00070538
VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies treatment 1 completed NCT04571138
A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma No drug interventions treatment 1 / 2 recruiting NCT00248443
Réa-MiniMax: Severe Acute Respiratory Failure in Hematology and Cancer Patients Without Bronchoalveolar Lavage No drug interventions diagnostic 3 completed NCT01861093
Safety Study of Cord Blood Units for Stem Cell Transplants No drug interventions treatment 2 recruiting NCT02188706
A Leukemia SPORE Phase II Clinical Trial Comparing Decitabine Versus Decitabine/Carboplatin and Decitabine/Arsenic for the Treatment of Relapsed, Refractory, and Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) treatment 2 active_not_recruiting NCT03273829
Study of Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children With Relapsed or Refractory Solid Tumors and Leukemias treatment 1 recruiting NCT00005846
Tipifarnib in Treating Patients With Myeloproliferative Disorders treatment 1 / 2 unknown_status NCT00475384
Haploidentical Transplantation in Patients With Acute Leukemia and Myelodysplasia treatment 1 completed NCT00960050
Methemoglobinemia in Patients With Childhood Hematologic Cancer or Aplastic Anemia Treated With Dapsone No drug interventions Not Available 1 unknown_status NCT01041703
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia treatment 3 recruiting NCT01326377
ON 01910.Na for Intermediate1-2, or High Risk Trisomy 8 Myelodysplastic Syndrome (MDS) treatment 2 completed NCT00810966
ABT-888 and Cyclophosphamide in Treating Patients With Solid Tumors or Lymphoma That Did Not Respond to Previous Therapy treatment 1 active_not_recruiting NCT00445666
Tumor-Infiltrating Lymphocytes in Treating Patients With Persistent or Recurrent B-Cell Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia or Multiple Myeloma After a Previous Donor Stem Cell Transplant No drug interventions treatment 1 active_not_recruiting NCT00066300
Allogeneic Peripheral Stem Cell Transplantation Followed By Donor Lymphocyte Infusions in Treating Patients With Hematologic Cancer treatment 2 active_not_recruiting NCT00502385
Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML No drug interventions treatment 1 completed NCT01313689
Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia treatment 3 completed NCT03466944
PUMA (Paediatric Osseous Marrow Assessment) No drug interventions Not Available Not Available recruiting NCT03594955
First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome No drug interventions treatment 1 / 2 terminated NCT02310997
Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT) No drug interventions treatment 2 terminated NCT05473325
Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY) No drug interventions Not Available Not Available not_yet_recruiting NCT01941680
High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant No drug interventions Not Available Not Available completed NCT00380653
Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic Syndromes No drug interventions treatment 1 completed NCT00743028
Assess the Oral Bioavailability of New ABT-263 Formulations treatment 1 completed NCT02452099
Impact of DMSO Concentrations on Hematopoietic Recovery After Autologous HSC Transplantation. No drug interventions treatment Not Available completed NCT01031641
Refinement of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Via Cognitive Interviewing and Usability Testing No drug interventions Not Available Not Available completed NCT00796562
Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy treatment 2 completed NCT00664677
Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia No drug interventions treatment 1 terminated